MINK
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0MZ66 | T455 | Sugiyama | SHTN1 KIAA1598 | KPESSKGCEsAVDELKGILGtLNKSTSSRsLKsLDPENsEt |
| A4UGR9 | S1417 | Sugiyama | XIRP2 CMYA3 | IEADEIGDVRMAKYKLMNQAsPEIQKEEIIRADLRNIMVNL |
| A5A3E0 | S939 | Sugiyama | POTEF A26C1B | VALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPE |
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| A6NMY6 | T31 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | LsLEGDHstPPsAyGsVKAytNFDAERDALNIEtAIKTKGV |
| A6NMY6 | T44 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | yGsVKAytNFDAERDALNIEtAIKTKGVDEVTIVNIVTNRD |
| O00151 | T78 | Sugiyama | PDLIM1 CLIM1 CLP36 | TSNMTHLEAQNRIKGCTDNLtLtVARsEHKVWsPLVtEEGK |
| O00151 | T80 | Sugiyama | PDLIM1 CLIM1 CLP36 | NMTHLEAQNRIKGCTDNLtLtVARsEHKVWsPLVtEEGKRH |
| O00299 | T45 | Sugiyama | CLIC1 G6 NCC27 | PFSQRLFMVLWLKGVTFNVTtVDtKRRTETVQKLCPGGQLP |
| O00299 | T48 | Sugiyama | CLIC1 G6 NCC27 | QRLFMVLWLKGVTFNVTtVDtKRRTETVQKLCPGGQLPFLL |
| O00571 | T156 | Sugiyama | DDX3X DBX DDX3 | WSKPLPPSERLEQELFsGGNtGINFEKYDDIPVEATGNNCP |
| O14744 | T80 | Sugiyama | PRMT5 HRMT1L5 IBP72 JBP1 SKB1 | KNRPGPQTRSDLLLSGRDWNtLIVGKLSPWIRPDSKVEKIR |
| O14818 | T147 | Sugiyama | PSMA7 HSPC | FGISALIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKS |
| O14818 | T152 | Sugiyama | PSMA7 HSPC | LIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFL |
| O15067 | S1053 | Sugiyama | PFAS KIAA0361 | RGLRERMGPSYCLPPTFPKAsVPREPGGPsPRVAILREEGS |
| O15143 | S323 | Sugiyama | ARPC1B ARC41 | QNLDKKAssEGGtAAGAGLDsLHKNsVsQIsVLsGGKAKCS |
| O15143 | T315 | Sugiyama | ARPC1B ARC41 | GLTARERFQNLDKKAssEGGtAAGAGLDsLHKNsVsQIsVL |
| O15212 | T107 | Sugiyama | PFDN6 HKE2 PFD6 | IKRYESQLRDLERQsEQQREtLAQLQQEFQRAQAAKAGAPG |
| O15371 | T226 | Sugiyama | EIF3D EIF3S7 | FDRITTRSEKPLRSIKRIFHtVTtTDDPVIRKLAKTQGNVF |
| O15371 | T229 | Sugiyama | EIF3D EIF3S7 | ITTRSEKPLRSIKRIFHtVTtTDDPVIRKLAKTQGNVFATD |
| O15371 | T49 | Sugiyama | EIF3D EIF3S7 | PyQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQY |
| O15523 | T154 | Sugiyama | DDX3Y DBY | WSKPLPPSERLEQELFsGGNtGINFEKYDDIPVEATGSNCP |
| O43175 | T353 | Sugiyama | PHGDH PGDH3 | IGLAEALGTLMRAWAGSPKGtIQVITQGtsLKNAGNCLsPA |
| O43175 | T361 | Sugiyama | PHGDH PGDH3 | TLMRAWAGSPKGtIQVITQGtsLKNAGNCLsPAVIVGLLKE |
| O43175 | T78 | Sugiyama | PHGDH PGDH3 | KVTADVINAAEKLQVVGRAGtGVDNVDLEAAtRKGILVMNT |
| O43175 | T89 | Sugiyama | PHGDH PGDH3 | KLQVVGRAGtGVDNVDLEAAtRKGILVMNTPNGNSLSAAEL |
| O43278 | T334 | Sugiyama | SPINT1 HAI1 UNQ223/PRO256 | AQATFPQGPSMERRHPVCSGtCQPTQFRCSNGCCIDSFLEC |
| O43390 | T137 | Sugiyama | HNRNPR HNRPR | ESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O43399 | S84 | Sugiyama | TPD52L2 | RQVLAAKERHCGELKRRLGLstLGELKQNLsRsWHDVQVss |
| O43423 | T101 | Sugiyama | ANP32CP PP32R1 | EKCPNLTHLYLSGNKIKDLstIEPLKQLENLKSLDLFNCEV |
| O43615 | T198 | Sugiyama | TIMM44 MIMT44 TIM44 | ALsQGVEsVKKEIDDsVLGQtGPyRRPQRLRKRTEFAGDKF |
| O43707 | S507 | Sugiyama | ACTN4 | DsHNVNtRCQKICDQWDALGsLtHsRREALEKTEKQLEAID |
| O43707 | S511 | Sugiyama | ACTN4 | VNtRCQKICDQWDALGsLtHsRREALEKTEKQLEAIDQLHL |
| O43707 | T359 | Sugiyama | ACTN4 | RRVHKPPKVQEKCQLEINFNtLQtKLRLSNRPAFMPSEGKM |
| O43707 | T362 | Sugiyama | ACTN4 | HKPPKVQEKCQLEINFNtLQtKLRLSNRPAFMPSEGKMVSD |
| O43707 | T443 | Sugiyama | ACTN4 | sIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDL |
| O43707 | T445 | Sugiyama | ACTN4 | HEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDLAA |
| O60361 | T88 | Sugiyama | NME2P1 | VVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHGsDsV |
| O60506 | T134 | Sugiyama | SYNCRIP HNRPQ NSAP1 | DSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O60716 | S230 | Sugiyama | CTNND1 KIAA0384 | PDGysRHyEDGyPGGsDNyGsLsRVtRIEERyRPsMEGyRA |
| O60716 | T869 | Sugiyama | CTNND1 KIAA0384 | FQVNLNNAsRsQssHsyDDstLPLIDRNQKsDKKPDREEIQ |
| O60841 | T92 | Sugiyama | EIF5B IF2 KIAA0741 | IKADREtVAVKPTENNEEEFtsKDKKKKGQKGKKQsFDDND |
| O75116 | S873 | Sugiyama | ROCK2 KIAA0619 | QDADGQMKELQDQLEAEQyFsTLyKtQVRELKEECEEKTKL |
| O75116 | T878 | Sugiyama | ROCK2 KIAA0619 | QMKELQDQLEAEQyFsTLyKtQVRELKEECEEKTKLGKELQ |
| O75116 | Y876 | Sugiyama | ROCK2 KIAA0619 | DGQMKELQDQLEAEQyFsTLyKtQVRELKEECEEKTKLGKE |
| O75369 | T907 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | PLPGDAVKDLDIIDNyDysHtVKYtPtQQGNMQVLVTYGGD |
| O75390 | T335 | Sugiyama | CS | LQKEVGKDVSDEKLRDYIWNtLNSGRVVPGyGHAVLRKTDP |
| O75534 | T431 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | KKLPKGTVSFHSHSDHRFLGtVEKEATFSNPKTtsPNKGKE |
| O75821 | T190 | Sugiyama | EIF3G EIF3S4 | PYKDtLGPMQKELAEQLGLstGEKEKLPGELEPVQAtQNKt |
| O75821 | T240 | Sugiyama | EIF3G EIF3S4 | DGAsRRGESMQPNRRADDNAtIRVtNLSEDTRETDLQELFR |
| O76021 | T45 | Sugiyama | RSL1D1 CATX11 CSIG PBK1 L12 | PTARKQLDKEQVRKAVDALLtHCKSRKNNYGLLLNENESLF |
| O95373 | T968 | Sugiyama | IPO7 RANBP7 | IIDDEDNPVDEYQIFKAIFQtIQNRNPVWyQALTHGLNEEQ |
| O95373 | T997 | Sugiyama | IPO7 RANBP7 | yQALTHGLNEEQRKQLQDIAtLADQRRAAHESKMIEKHGGY |
| O95456 | S183 | Sugiyama | PSMG1 C21LRP DSCR2 PAC1 | QITILTCRHVTDYKTSEsTGsLPsPFLRALKTQNFKDSACC |
| O95626 | T105 | Sugiyama | ANP32D PP32R2 | EKCPNLIHLNLSGNKIKDLstIEPLKKLENLESLDLFTCEV |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O95757 | S587 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | RLNQTLKKGKVKsIDLPIQssLCRQLGQDLLNsyIENEGKM |
| O95757 | Y600 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | IDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERNDA |
| O95817 | T242 | Sugiyama | BAG3 BIS | QPsFHQAQKTHyPAQQGEyQtHQPVyHKIQGDDWEPRPLRA |
| O95835 | T1079 | PSP | LATS1 WARTS | DtLNGWYKNGKHPEHAFYEFtFRRFFDDNGYPYNYPKPIEY |
| O95999 | S85 | Sugiyama | BCL10 CIPER CLAP | AGKLLDYLQENPKGLDtLVEsIRREKTQNFLIQKITDEVLK |
| O95999 | T81 | Sugiyama | BCL10 CIPER CLAP | SRKRAGKLLDYLQENPKGLDtLVEsIRREKTQNFLIQKITD |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | S167 | Sugiyama | LDHA PIG19 | AWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHG |
| P00338 | S69 | Sugiyama | LDHA PIG19 | ALVDVIEDKLKGEMMDLQHGsLFLRTPKIVSGKDyNVTANs |
| P00338 | T275 | Sugiyama | LDHA PIG19 | SVADLAESIMKNLRRVHPVstMIKGLYGIKDDVFLSVPCIL |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00390 | T507 | Sugiyama | GSR GLUR GRD1 | MLQGFAVAVKMGATKADFDNtVAIHPtssEELVtLR_____ |
| P00390 | T520 | Sugiyama | GSR GLUR GRD1 | TKADFDNtVAIHPtssEELVtLR__________________ |
| P00492 | T211 | Sugiyama | HPRT1 HPRT | YALDYNEYFRDLNHVCVISEtGKAKYKA_____________ |
| P00558 | S399 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | CCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDALsNI__ |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P00558 | T378 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EVVKAtsRGCItIIGGGDtAtCCAKWNtEDKVsHVstGGGA |
| P00558 | T394 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDAL |
| P01111 | T158 | Sugiyama | NRAS HRAS1 | GIPFIETSAKTRQGVEDAFytLVREIRQYRMKKLNSSDDGT |
| P01112 | T158 | Sugiyama | HRAS HRAS1 | GIPYIEtSAKtRQGVEDAFytLVREIRQHKLRKLNPPDESG |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P02786 | T336 | Sugiyama | TFRC | FNHTQFPPSRSSGLPNIPVQtISRAAAEKLFGNMEGDCPSD |
| P02786 | T362 | Sugiyama | TFRC | AEKLFGNMEGDCPSDWKTDstCRMVTSESKNVKLTVSNVLK |
| P04040 | S515 | Sugiyama | CAT | ALLDKYNAEKPKNAIHtFVQsGsHLAAREKANL________ |
| P04040 | S517 | Sugiyama | CAT | LDKYNAEKPKNAIHtFVQsGsHLAAREKANL__________ |
| P04040 | T434 | Sugiyama | CAT | QQPSALEHSIQYSGEVRRFNtANDDNVtQVRAFyVNVLNEE |
| P04040 | T511 | Sugiyama | CAT | SHIQALLDKYNAEKPKNAIHtFVQsGsHLAAREKANL____ |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | T119 | Sugiyama | ALDOA ALDA | KsKGGVVGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYK |
| P04075 | T123 | Sugiyama | ALDOA ALDA | GVVGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYKKDGA |
| P04075 | T124 | Sugiyama | ALDOA ALDA | VVGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYKKDGAD |
| P04075 | T125 | Sugiyama | ALDOA ALDA | VGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYKKDGADF |
| P04075 | T253 | Sugiyama | ALDOA ALDA | MVtPGHACTQKFsHEEIAMAtVtALRRTVPPAVTGItFLsG |
| P04075 | T255 | Sugiyama | ALDOA ALDA | tPGHACTQKFsHEEIAMAtVtALRRTVPPAVTGItFLsGGQ |
| P04083 | T223 | Sugiyama | ANXA1 ANX1 LPC1 | ARALyEAGERRKGtDVNVFNtILttRSyPQLRRVFQKYTKY |
| P04083 | T226 | Sugiyama | ANXA1 ANX1 LPC1 | LyEAGERRKGtDVNVFNtILttRSyPQLRRVFQKYTKYSKH |
| P04150 | S617 | GPS6 | NR3C1 GRL | QYSWMFLMAFALGWRSYRQSsANLLCFAPDLIINEQRMtLP |
| P04150 | T524 | GPS6|PSP | NR3C1 GRL | TTGVsQETSENPGNKtIVPAtLPQLTPTLVSLLEVIEPEVL |
| P04150 | T562 | PSP | NR3C1 GRL | EVLYAGYDSSVPDStWRIMTtLNMLGGRQVIAAVKWAKAIP |
| P04150 | T635 | PSP | NR3C1 GRL | QSsANLLCFAPDLIINEQRMtLPCMYDQCKHMLYVSSELHR |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | T104 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | KIKWGDAGAEyVVEstGVFttMEKAGAHLQGGAKRVIIsAP |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04406 | T99 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | ERDPsKIKWGDAGAEyVVEstGVFttMEKAGAHLQGGAKRV |
| P05362 | T454 | Sugiyama | ICAM1 | DGtFPLPIGEsVtVtRDLEGtyLCRARSTQGEVTRKVTVNV |
| P05362 | Y455 | Sugiyama | ICAM1 | GtFPLPIGEsVtVtRDLEGtyLCRARSTQGEVTRKVTVNVL |
| P05388 | T128 | Sugiyama | RPLP0 | PAAARAGAIAPCEVtVPAQNtGLGPEKTSFFQALGItTKIS |
| P05783 | T404 | Sugiyama | KRT18 CYK18 PIG46 | LEDGEDFNLGDALDssNsMQtIQKtTTRRIVDGKVVsETND |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P06733 | S14 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | _______MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAA |
| P06733 | S291 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IsPDQLADLyKsFIKDyPVVsIEDPFDQDDWGAWQKFtAsA |
| P06733 | S37 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NPtVEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRY |
| P06733 | S40 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | VEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGK |
| P06733 | T100 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | KKLNVtEQEKIDKLMIEMDGtENKsKFGANAILGVsLAVCK |
| P06733 | T19 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | __MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGA |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | T26 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEA |
| P06733 | T41 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKG |
| P06733 | T55 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | VPsGAstGIyEALELRDNDKtRYMGKGVSKAVEHINKtIAP |
| P06733 | Y287 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | PsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDDWGAWQKF |
| P06748 | S137 | Sugiyama | NPM1 NPM | VAVEEDAEsEDEEEEDVKLLsIsGKRsAPGGGsKVPQKKVK |
| P06748 | S254 | Sugiyama | NPM1 NPM | tPKtPKGPssVEDIKAKMQAsIEKGGsLPKVEAKFINyVKN |
| P06748 | S260 | Sugiyama | NPM1 NPM | GPssVEDIKAKMQAsIEKGGsLPKVEAKFINyVKNCFRMtD |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S168 | Sugiyama | LDHB | TWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIHPSSCHG |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T276 | Sugiyama | LDHB | SVADLIESMLKNLSRIHPVStMVKGMYGIENEVFLSLPCIL |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | S399 | Sugiyama | PGK2 PGKB | CCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEALSNM__ |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07205 | T394 | Sugiyama | PGK2 PGKB | GDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEAL |
| P07237 | T117 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | RGyPtIKFFRNGDTASPKEytAGREADDIVNWLKKRTGPAA |
| P07355 | T31 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | LsLEGDHstPPsAyGsVKAytNFDAERDALNIEtAIKTKGV |
| P07355 | T44 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | yGsVKAytNFDAERDALNIEtAIKTKGVDEVtIVNILTNRS |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07437 | T285 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | FFMPGFAPLtsRGsQQyRALtVPELtQQVFDAKNMMAACDP |
| P07437 | T290 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | FAPLtsRGsQQyRALtVPELtQQVFDAKNMMAACDPRHGRy |
| P07437 | T55 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPGtMDs |
| P07437 | T72 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | NEAtGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| P07737 | S133 | Sugiyama | PFN1 | LMGKEGVHGGLINKKCyEMAsHLRRsQY_____________ |
| P07737 | T65 | Sugiyama | PFN1 | PAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQDGEFs |
| P07814 | S335 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGCMRDPt |
| P07814 | T1105 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | SALEKEKTHVADFAPEVAWVtRSGKTELAEPIAIRPTsEtV |
| P07858 | T95 | Sugiyama | CTSB CPSB | TEDLKLPAsFDAREQWPQCPtIKEIRDQGSCGSCWAFGAVE |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07864 | S167 | Sugiyama | LDHC LDH3 LDHX | VWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVHPTSCHG |
| P07900 | S165 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTK |
| P07900 | S63 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPN |
| P07900 | S641 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DNstMGyMAAKKHLEINPDHsIIEtLRQKAEADKNDKSVKD |
| P07900 | S72 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ssDALDKIRyEsLtDPsKLDsGKELHINLIPNKQDRtLtIV |
| P07900 | T317 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | WtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P07900 | T495 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | VsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLRKHG |
| P07900 | T624 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | yGWTANMERIMKAQALRDNstMGyMAAKKHLEINPDHsIIE |
| P07900 | T645 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MGyMAAKKHLEINPDHsIIEtLRQKAEADKNDKSVKDLVIL |
| P07900 | T65 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPNKQ |
| P07900 | T88 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | sKLDsGKELHINLIPNKQDRtLtIVDtGIGMTKADLINNLG |
| P07900 | T94 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KELHINLIPNKQDRtLtIVDtGIGMTKADLINNLGtIAKSG |
| P07900 | Y465 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IKLGIHEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMK |
| P07900 | Y61 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KEIFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLI |
| P08195 | S253 | Sugiyama | SLC3A2 MDU1 | FQGHGAGNLAGLKGRLDyLssLKVKGLVLGPIHKNQKDDVA |
| P08195 | T599 | Sugiyama | SLC3A2 MDU1 | QASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEPH |
| P08238 | S160 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTK |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S58 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| P08238 | S615 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tyGWTANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIV |
| P08238 | S67 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AsDALDKIRyEsLtDPsKLDsGKELKIDIIPNPQERtLtLV |
| P08238 | T309 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | WtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08238 | T467 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | NRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyIt |
| P08238 | T60 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPNPQ |
| P08238 | T616 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | yGWTANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIVE |
| P08238 | T637 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MGyMMAKKHLEINPDHPIVEtLRQKAEADKNDKAVKDLVVL |
| P08238 | T83 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sKLDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLG |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08238 | T89 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSG |
| P08238 | Y457 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMK |
| P08238 | Y56 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEIFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDII |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P08729 | T289 | Sugiyama | KRT7 SCL | EEMAKCSRAEAEAWyQTKFEtLQAQAGKHGDDLRNTRNEIS |
| P08729 | Y283 | Sugiyama | KRT7 SCL | EVKAQYEEMAKCSRAEAEAWyQTKFEtLQAQAGKHGDDLRN |
| P08758 | S44 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | LRKAMKGLGtDEEsILtLLtsRsNAQRQEISAAFKTLFGRD |
| P08758 | T23 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | QVLRGtVtDFPGFDERADAEtLRKAMKGLGtDEEsILtLLt |
| P08758 | T40 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | DAEtLRKAMKGLGtDEEsILtLLtsRsNAQRQEISAAFKTL |
| P08758 | T43 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | tLRKAMKGLGtDEEsILtLLtsRsNAQRQEISAAFKTLFGR |
| P08865 | T94 | Sugiyama | RPSA LAMBR LAMR1 | VsVIssRNtGQRAVLKFAAAtGAtPIAGRFtPGTFTNQIQA |
| P08865 | T97 | Sugiyama | RPSA LAMBR LAMR1 | IssRNtGQRAVLKFAAAtGAtPIAGRFtPGTFTNQIQAAFR |
| P09104 | S37 | Sugiyama | ENO2 | NPtVEVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRY |
| P09104 | S40 | Sugiyama | ENO2 | VEVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGK |
| P09104 | T41 | Sugiyama | ENO2 | EVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKG |
| P09211 | T68 | Sugiyama | GSTP1 FAEES3 GST3 | CLyGQLPKFQDGDLtLyQsNtILRHLGRTLGLYGKDQQEAA |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09651 | S368 | Sugiyama | HNRNPA1 HNRPA1 | FAKPRNQGGyGGssssssyGsGRRF________________ |
| P09874 | T397 | Sugiyama | PARP1 ADPRT PPOL | PAAVNSsAsADKPLSNMKILtLGKLSRNKDEVKAMIEKLGG |
| P09972 | T119 | Sugiyama | ALDOC ALDC | QDKGIVVGIKVDKGVVPLAGtDGEtttQGLDGLsERCAQYK |
| P09972 | T125 | Sugiyama | ALDOC ALDC | VGIKVDKGVVPLAGtDGEtttQGLDGLsERCAQYKKDGADF |
| P0DPH7 | T51 | Sugiyama | TUBA3C TUBA2 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P0DPH7 | T56 | Sugiyama | TUBA3C TUBA2 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVVD |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10809 | S453 | Sugiyama | HSPD1 HSP60 | EEGIVLGGGCALLRCIPALDsLtPANEDQKIGIEIIKRTLK |
| P10809 | S67 | Sugiyama | HSPD1 HSP60 | LADAVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVAKsIDLK |
| P10809 | T117 | Sugiyama | HSPD1 HSP60 | LVQDVANNtNEEAGDGtttAtVLARSIAKEGFEKISKGANP |
| P10809 | T173 | Sugiyama | HSPD1 HSP60 | AELKKQsKPVttPEEIAQVAtIsANGDKEIGNIIsDAMKKV |
| P10809 | T61 | Sugiyama | HSPD1 HSP60 | LQGVDLLADAVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVA |
| P11142 | S340 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | ALRDAKLDKsQIHDIVLVGGstRIPKIQKLLQDFFNGKELN |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T37 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P11142 | T45 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtN |
| P11142 | T47 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtNtV |
| P11142 | T64 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FtDtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQ |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11586 | T128 | Sugiyama | MTHFD1 MTHFC MTHFD | SINTEEVINAIAPEKDVDGLtsINAGKLARGDLNDCFIPCt |
| P11940 | T191 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | GRFKSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLF |
| P11940 | T379 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | AtKPLyVALAQRKEERQAHLtNQyMQRMASVRAVPNPVINP |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P12268 | T252 | Sugiyama | IMPDH2 IMPD2 | DYPLASKDAKKQLLCGAAIGtHEDDKYRLDLLAQAGVDVVV |
| P12270 | T1039 | Sugiyama | TPR | QDDKRRAIESMEQQLSELKKtLSSVQNEVQEALQRASTALS |
| P12277 | S129 | Sugiyama | CKB CKBB | DLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPHCsRG |
| P12277 | S163 | Sugiyama | CKB CKBB | PPHCsRGERRAIEKLAVEALssLDGDLAGRyyALKsMtEAE |
| P12814 | T340 | Sugiyama | ACTN1 | RRLHKPPKVQEKCQLEINFNtLQtKLRLsNRPAFMPsEGRM |
| P12814 | T343 | Sugiyama | ACTN1 | HKPPKVQEKCQLEINFNtLQtKLRLsNRPAFMPsEGRMVSD |
| P13639 | S38 | Sugiyama | EEF2 EF2 | NIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEtRFtD |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13639 | T482 | Sugiyama | EEF2 EF2 | EDVPCGNIVGLVGVDQFLVKtGtIttFEHAHNMRVMKFsVs |
| P13639 | T484 | Sugiyama | EEF2 EF2 | VPCGNIVGLVGVDQFLVKtGtIttFEHAHNMRVMKFsVsPV |
| P13639 | T486 | Sugiyama | EEF2 EF2 | CGNIVGLVGVDQFLVKtGtIttFEHAHNMRVMKFsVsPVVR |
| P13639 | T5 | Sugiyama | EEF2 EF2 | ________________MVNFtVDQIRAIMDKKANIRNMsVI |
| P13639 | T735 | Sugiyama | EEF2 EF2 | HRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCPEQV |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13667 | S495 | Sugiyama | PDIA4 ERP70 ERP72 | NAAILDEsGKKFAMEPEEFDsDtLREFVtAFKKGKLKPVIK |
| P13667 | S567 | Sugiyama | PDIA4 ERP70 ERP72 | LIEFYAPWCGHCKQLEPVyNsLAKKYKGQKGLVIAKMDATA |
| P13667 | T497 | Sugiyama | PDIA4 ERP70 ERP72 | AILDEsGKKFAMEPEEFDsDtLREFVtAFKKGKLKPVIKSQ |
| P13667 | T503 | Sugiyama | PDIA4 ERP70 ERP72 | GKKFAMEPEEFDsDtLREFVtAFKKGKLKPVIKSQPVPKNN |
| P13674 | T529 | Sugiyama | P4HA1 P4HA | NKWVSNKWLHERGQEFRRPCtLSELE_______________ |
| P13861 | T104 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVIHPKTD |
| P13929 | S37 | Sugiyama | ENO3 | NPtVEVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRY |
| P13929 | S40 | Sugiyama | ENO3 | VEVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGK |
| P13929 | T19 | Sugiyama | ENO3 | __MAMQKIFAREILDsRGNPtVEVDLHtAKGRFRAAVPsGA |
| P13929 | T26 | Sugiyama | ENO3 | IFAREILDsRGNPtVEVDLHtAKGRFRAAVPsGAstGIyEA |
| P13929 | T41 | Sugiyama | ENO3 | EVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKG |
| P13987 | T76 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | AGLQVYNKCWKFEHCNFNDVtTRLRENELtyyCCKKDLCNF |
| P14314 | S445 | Sugiyama | PRKCSH G19P1 | YRLCPFKLVSQKPKLGGsPtsLGtWGsWIGPDHDKFSAMKy |
| P14314 | S451 | Sugiyama | PRKCSH G19P1 | KLVSQKPKLGGsPtsLGtWGsWIGPDHDKFSAMKyEQGtGC |
| P14314 | S478 | Sugiyama | PRKCSH G19P1 | DKFSAMKyEQGtGCWQGPNRstTVRLLCGKEtMVtStTEPS |
| P14314 | T448 | Sugiyama | PRKCSH G19P1 | CPFKLVSQKPKLGGsPtsLGtWGsWIGPDHDKFSAMKyEQG |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14618 | S77 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sVEtLKEMIKsGMNVARLNFsHGtHEyHAEtIKNVRtAtEs |
| P14618 | T45 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | TFLEHMCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMI |
| P14618 | T454 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SGRSAHQVARYRPRAPIIAVtRNPQtARQAHLYRGIFPVLC |
| P14618 | T459 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | HQVARYRPRAPIIAVtRNPQtARQAHLYRGIFPVLCKDPVQ |
| P14618 | T50 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | MCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMIKsGMN |
| P14618 | T87 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sGMNVARLNFsHGtHEyHAEtIKNVRtAtEsFAsDPILyRP |
| P14625 | S515 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQ |
| P14625 | S523 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | RtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMAG |
| P14625 | S680 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | RIMKAQAYQtGKDIstNyyAsQKKTFEINPRHPLIRDMLRR |
| P14625 | T171 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSEL |
| P14625 | T519 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | DHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIy |
| P14868 | T327 | Sugiyama | DARS1 DARS PIG40 | ADTMVQIFKGLQERFQTEIQtVNKQFPCEPFKFLEPTLRLE |
| P15259 | T96 | Sugiyama | PGAM2 PGAMM | QMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEEQVKIWR |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P15531 | T103 | Sugiyama | NME1 NDPKA NM23 | VVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHGsDsV |
| P15880 | T232 | Sugiyama | RPS2 RPS4 | KLLMMAGIDDCytsARGCtAtLGNFAKATFDAISKTysyLt |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P17066 | T49 | Sugiyama | HSPA6 HSP70B' | EILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHNtV |
| P17174 | S106 | Sugiyama | GOT1 | RLALGDDsPALKEKRVGGVQsLGGtGALRIGADFLARWYNG |
| P17174 | T110 | Sugiyama | GOT1 | GDDsPALKEKRVGGVQsLGGtGALRIGADFLARWYNGTNNK |
| P17844 | S520 | Sugiyama | DDX5 G17P1 HELR HLR1 | GKRGGFNTFRDRENYDRGYssLLKRDFGAKTQNGVYSAANY |
| P18124 | T17 | Sugiyama | RPL7 | ____MEGVEEKKKEVPAVPEtLKKKRRNFAELKIKRLRKKF |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18621 | T12 | Sugiyama | RPL17 | _________MVRysLDPENPtKsCKSRGSNLRVHFKNtRET |
| P18621 | T79 | Sugiyama | RPL17 | PFRRYNGGVGRCAQAKQWGWtQGRWPKKSAEFLLHMLKNAE |
| P18669 | S155 | Sugiyama | PGAM1 PGAMA CDABP0006 | NIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQI |
| P18669 | T159 | Sugiyama | PGAM1 PGAMA CDABP0006 | DRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQIKEGK |
| P18669 | T96 | Sugiyama | PGAM1 PGAMA CDABP0006 | QMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQVKIWR |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | T464 | Sugiyama | NCL | KTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWsGE |
| P20618 | S157 | Sugiyama | PSMB1 PSC5 | IIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLL |
| P20618 | S162 | Sugiyama | PSMB1 PSC5 | DEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLLDNQVG |
| P20618 | Y158 | Sugiyama | PSMB1 PSC5 | IGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLLD |
| P21980 | T368 | Sugiyama | TGM2 | QPGYEGWQALDPTPQEKsEGtyCCGPVPVRAIKEGDLstKy |
| P22090 | S204 | Sugiyama | RPS4Y1 RPS4Y PRO2646 | IGGANLGRVGVITNRERHPGsFDVVHVKDANGNSFATRLSN |
| P22314 | T600 | Sugiyama | UBA1 A1S9T UBE1 | ARMYMDRRCVYYRKPLLESGtLGtKGNVQVVIPFLTESySS |
| P22392 | T103 | Sugiyama | NME2 NM23B | VVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHGsDsV |
| P22626 | T140 | Sugiyama | HNRNPA2B1 HNRPA2B1 | KEDTEEHHLRDyFEEYGKIDtIEIItDRQsGKKRGFGFVtF |
| P23246 | S283 | Sugiyama | SFPQ PSF | GPGGRsEEKIsDsEGFKANLsLLRRPGEKTyTQRCRLFVGN |
| P23284 | T81 | Sugiyama | PPIB CYPB | IFGLFGKTVPKTVDNFVALAtGEKGFGYKNSKFHRVIKDFM |
| P23381 | S358 | Sugiyama | WARS1 IFI53 WARS WRS | TFFPALQGAQTKMsAsDPNssIFLtDtAKQIKTKVNKHAFs |
| P23381 | S378 | Sugiyama | WARS1 IFI53 WARS WRS | sIFLtDtAKQIKTKVNKHAFsGGRDtIEEHRQFGGNCDVDV |
| P23381 | T207 | Sugiyama | WARS1 IFI53 WARS WRS | FNVPLVIQMTDDEKYLWKDLtLDQAysyAVENAKDIIACGF |
| P23381 | T364 | Sugiyama | WARS1 IFI53 WARS WRS | QGAQTKMsAsDPNssIFLtDtAKQIKTKVNKHAFsGGRDtI |
| P23381 | T383 | Sugiyama | WARS1 IFI53 WARS WRS | DtAKQIKTKVNKHAFsGGRDtIEEHRQFGGNCDVDVSFMYL |
| P23396 | T242 | Sugiyama | RPS3 OK/SW-cl.26 | PIsEQKGGKPEPPAMPQPVPtA___________________ |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23528 | T91 | Sugiyama | CFL1 CFL | FVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWAPESAPL |
| P23528 | Y89 | Sugiyama | CFL1 CFL | AtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| P23921 | T120 | Sugiyama | RRM1 RR1 | DLyNyINPHNGKHSPMVAKstLDIVLANKDRLNsAIIYDRD |
| P24752 | S218 | Sugiyama | ACAT1 ACAT MAT | ENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPV |
| P25705 | S198 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | GIIPRIsVREPMQTGIKAVDsLVPIGRGQRELIIGDRQTGK |
| P25786 | T11 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | __________MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQ |
| P25788 | S243 | Sugiyama | PSMA3 HC8 PSC8 | GRHEIVPKDIREEAEKyAKEsLKEEDEsDDDNM________ |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26232 | T37 | Sugiyama | CTNNA2 CAPR | LEIRTLTVERLLEPLVTQVTtLVNtsNKGPSGKKKGRSKKA |
| P26232 | T41 | Sugiyama | CTNNA2 CAPR | TLTVERLLEPLVTQVTtLVNtsNKGPSGKKKGRSKKAHVLA |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26373 | T24 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | SRNGMVLKPHFHKDWQRRVAtWFNQPARKIRRRKARQAKAR |
| P26447 | T15 | Sugiyama | S100A4 CAPL MTS1 | ______MACPLEKALDVMVstFHKYSGKEGDKFKLNKSELK |
| P26641 | T411 | Sugiyama | EEF1G EF1G PRO1608 | QVDyESyTWRKLDPGsEEtQtLVREyFSWEGAFQHVGKAFN |
| P27144 | T197 | Sugiyama | AK4 AK3 AK3L1 | VAKPVIELYKSRGVLHQFsGtEtNKIWPYVYTLFSNKITPI |
| P27797 | T181 | Sugiyama | CALR CRTC | IRCKDDEFTHLytLIVRPDNtyEVKIDNsQVEsGsLEDDWD |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P27797 | Y172 | Sugiyama | CALR CRTC | GKNVLINKDIRCKDDEFTHLytLIVRPDNtyEVKIDNsQVE |
| P28066 | T161 | Sugiyama | PSMA5 | LLFGGVDEKGPQLFHMDPsGtFVQCDARAIGsAsEGAQssL |
| P29401 | T342 | Sugiyama | TKT | GQALAKLGHAsDRIIALDGDtKNstFsEIFKKEHPDRFIEC |
| P29401 | T444 | Sugiyama | TKT | DGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAANT |
| P29401 | T454 | Sugiyama | TKT | LAMFRsVPtstVFyPsDGVAtEKAVELAANTKGICFIRTsR |
| P30041 | T48 | Sugiyama | PRDX6 AOP2 KIAA0106 | FLGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKRNVKL |
| P30050 | T128 | Sugiyama | RPL12 | EIVNIARQMRHRSLARELsGtIKEILGtAQsVGCNVDGRHP |
| P30050 | T135 | Sugiyama | RPL12 | QMRHRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDI |
| P30084 | T169 | Sugiyama | ECHS1 | CDIIYAGEKAQFAQPEILIGtIPGAGGtQRLTRAVGKsLAM |
| P30084 | T176 | Sugiyama | ECHS1 | EKAQFAQPEILIGtIPGAGGtQRLTRAVGKsLAMEMVLTGD |
| P30084 | T269 | Sugiyama | ECHS1 | EMTLTEGSKLEKKLFySTFAtDDRKEGMTAFVEKRKANFKD |
| P30084 | Y264 | Sugiyama | ECHS1 | VNAAFEMTLTEGSKLEKKLFySTFAtDDRKEGMTAFVEKRK |
| P30086 | S109 | Sugiyama | PEBP1 PBP PEBP | VVNMKGNDIssGtVLsDyVGsGPPKGtGLHRyVWLVyEQDR |
| P30086 | S98 | Sugiyama | PEBP1 PBP PEBP | DPKYREWHHFLVVNMKGNDIssGtVLsDyVGsGPPKGtGLH |
| P30101 | T485 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKKKAQEDL |
| P30740 | S72 | Sugiyama | SERPINB1 ELANH2 MNEI PI2 | AQLSKTFHFNTVEEVHSRFQsLNADINKRGASYILKLANRL |
| P30876 | S882 | Sugiyama | POLR2B | GDDVIIGKTVtLPENEDELEstNRRYTKRDCSTFLRTSETG |
| P30876 | T872 | Sugiyama | POLR2B | GLIAPGVRVSGDDVIIGKTVtLPENEDELEstNRRYTKRDC |
| P30876 | T883 | Sugiyama | POLR2B | DDVIIGKTVtLPENEDELEstNRRYTKRDCSTFLRTSETGI |
| P31150 | S213 | Sugiyama | GDI1 GDIL OPHN2 RABGDIA XAP4 | RTDDyLDQPCLETVNRIKLYsEsLARYGKsPYLyPLyGLGE |
| P31327 | S898 | Sugiyama | CPS1 | LYKMRDILNMEKTLKGLNsEsMtEEtLKRAKEIGFSDKQIS |
| P31327 | T903 | Sugiyama | CPS1 | DILNMEKTLKGLNsEsMtEEtLKRAKEIGFSDKQISKCLGL |
| P31943 | S285 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | NyCFsGMsDHRyGDGGstFQsttGHCVHMRGLPYRAtENDI |
| P31943 | T282 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | RDLNyCFsGMsDHRyGDGGstFQsttGHCVHMRGLPYRAtE |
| P31943 | T286 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yCFsGMsDHRyGDGGstFQsttGHCVHMRGLPYRAtENDIy |
| P31947 | T197 | Sugiyama | SFN HME1 | SVFHYEIANsPEEAISLAKTtFDEAMADLHtLsEDsyKDst |
| P31947 | T207 | Sugiyama | SFN HME1 | PEEAISLAKTtFDEAMADLHtLsEDsyKDstLIMQLLRDNL |
| P31948 | T243 | Sugiyama | STIP1 | KQALKEKELGNDAYKKKDFDtALKHYDKAKELDPtNMtyIT |
| P33176 | T809 | Sugiyama | KIF5B KNS KNS1 | VAKELQTLHNLRKLFVQDLAtRVKKSAEIDsDDTGGsAAQK |
| P33992 | T404 | Sugiyama | MCM5 CDC46 | GTAKSQLLKFVEKCsPIGVytsGKGSSAAGLtAsVMRDPss |
| P34897 | T276 | Sugiyama | SHMT2 | SGLVAAKVIPsPFKHADIVTtTTHKtLRGARSGLIFyRKGV |
| P34897 | T281 | Sugiyama | SHMT2 | AKVIPsPFKHADIVTtTTHKtLRGARSGLIFyRKGVKAVDP |
| P34931 | T39 | Sugiyama | HSPA1L | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P34931 | T47 | Sugiyama | HSPA1L | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQN |
| P34931 | T49 | Sugiyama | HSPA1L | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQNTV |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P34932 | T365 | Sugiyama | HSPA4 APG2 HSPH2 | TRIPAVKEKISKFFGKELsttLNADEAVTRGCALQCAILsP |
| P35080 | T61 | Sugiyama | PFN2 | QSITPIEIDMIVGKDREGFFtNGLtLGAKKCSVIRDSLyVD |
| P35080 | T65 | Sugiyama | PFN2 | PIEIDMIVGKDREGFFtNGLtLGAKKCSVIRDSLyVDGDCt |
| P35579 | T598 | Sugiyama | MYH9 | DYKADEWLMKNMDPLNDNIAtLLHQSSDKFVSELWKDVDRI |
| P35606 | S160 | Sugiyama | COPB2 | GHTHYVMQIVINPKDNNQFAsAsLDRtIKVWQLGsssPNFT |
| P35606 | T166 | Sugiyama | COPB2 | MQIVINPKDNNQFAsAsLDRtIKVWQLGsssPNFTLEGHEK |
| P35609 | T347 | Sugiyama | ACTN2 | RRKHKPPKVQEKCQLEINFNtLQtKLRISNRPAFMPSEGKM |
| P35609 | T350 | Sugiyama | ACTN2 | HKPPKVQEKCQLEINFNtLQtKLRISNRPAFMPSEGKMVSD |
| P35613 | S279 | Sugiyama | BSG UNQ6505/PRO21383 | TDSEDKALMNGSESRFFVsssQGRSELHIENLNMEADPGQy |
| P35658 | T860 | Sugiyama | NUP214 CAIN CAN KIAA0023 | LEQKKKQRHLLVPERETLFNtLANNREIINQQRKRLNHLVD |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P36578 | S63 | Sugiyama | RPL4 RPL1 | NLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGG |
| P36578 | S66 | Sugiyama | RPL4 RPL1 | KNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHR |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P36578 | T69 | Sugiyama | RPL4 RPL1 | RQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHRsGQ |
| P36578 | T84 | Sugiyama | RPL4 RPL1 | AEsWGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAP |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P37802 | T190 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | GKNVIGLQMGtNRGAsQAGMtGyGMPRQIL___________ |
| P38117 | T172 | Sugiyama | ETFB FP585 | QVTLEGDKLKVEREIDGGLEtLRLKLPAVVTADLRLNEPRy |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | T86 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | CVAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAK |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P39019 | S59 | Sugiyama | RPS19 | LAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsMTKIY |
| P39019 | T36 | Sugiyama | RPS19 | RALAAFLKKSGKLKVPEWVDtVKLAKHKELAPyDENWFytR |
| P39019 | T60 | Sugiyama | RPS19 | AKHKELAPyDENWFytRAAstARHLYLRGGAGVGsMTKIYG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P39687 | T105 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | EKCPNLTHLNLsGNKIKDLstIEPLKKLENLKsLDLFNCEV |
| P40429 | T153 | Sugiyama | RPL13A | RKFAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYRKKKQ |
| P40429 | T155 | Sugiyama | RPL13A | FAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYRKKKQLM |
| P40925 | T135 | Sugiyama | MDH1 MDHA | ALDKYAKKSVKVIVVGNPANtNCLtAsKSAPSIPKENFsCL |
| P40925 | T139 | Sugiyama | MDH1 MDHA | YAKKSVKVIVVGNPANtNCLtAsKSAPSIPKENFsCLtRLD |
| P40925 | T225 | Sugiyama | MDH1 MDHA | KEVGVyEALKDDsWLKGEFVttVQQRGAAVIKARKLssAMS |
| P40925 | T226 | Sugiyama | MDH1 MDHA | EVGVyEALKDDsWLKGEFVttVQQRGAAVIKARKLssAMSA |
| P41091 | T22 | Sugiyama | EIF2S3 EIF2G | AGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAtI |
| P41091 | T41 | Sugiyama | EIF2S3 EIF2G | ttLDVtKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAI |
| P41091 | T46 | Sugiyama | EIF2S3 EIF2G | tKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAISGVHt |
| P41223 | T115 | Sugiyama | BUD31 EDG2 | QGYENLCCLRCIQTRDtNFGtNCICRVPKSKLEVGRIIECT |
| P42166 | T137 | Sugiyama | TMPO LAP2 | NEDLLDQLVKyGVNPGPIVGttRKLYEKKLLKLREQGtEsR |
| P42167 | T137 | Sugiyama | TMPO LAP2 | NEDLLDQLVKyGVNPGPIVGtTRKLYEKKLLKLREQGTESR |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P42765 | T87 | Sugiyama | ACAA2 | IYLARHVGLRVGIPKETPALtINRLCGSGFQSIVNGCQEIC |
| P42772 | T95 | Sugiyama | CDKN2B MTS2 | ADPATLTRPVHDAAREGFLDtLVVLHRAGARLDVRDAWGRL |
| P43034 | T247 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | VKTFTGHREWVRMVRPNQDGtLIASCSNDQTVRVWVVATKE |
| P46013 | S2116 | Sugiyama | MKI67 | DKTTKIACKsPPPEsMDtPTstRRRPKtPLGKRDIVEELsA |
| P46013 | T2117 | Sugiyama | MKI67 | KTTKIACKsPPPEsMDtPTstRRRPKtPLGKRDIVEELsAL |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | T177 | Sugiyama | RPL5 MSTP030 | NKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHRK |
| P46778 | T124 | Sugiyama | RPL21 | sFLKRVKENDQKKKEAKEKGtWVQLKRQPAPPREAHFVRTN |
| P46782 | S75 | Sugiyama | RPS5 | RYAAKRFRKAQCPIVERLtNsMMMHGRNNGKKLMTVRIVKH |
| P46783 | T93 | Sugiyama | RPS10 | NEGIQYLRDyLHLPPEIVPAtLRRSRPETGRPRPKGLEGER |
| P46940 | T1471 | Sugiyama | IQGAP1 KIAA0051 | tLQEKKEKIQTGLKKLTELGtVDPKNKyQELINDIARDIRN |
| P47756 | S192 | Sugiyama | CAPZB | TVMLWLQTNKSGsGtMNLGGsLtRQMEKDEtVsDCsPHIAN |
| P47756 | T186 | Sugiyama | CAPZB | HYKLTSTVMLWLQTNKSGsGtMNLGGsLtRQMEKDEtVsDC |
| P47914 | T151 | Sugiyama | RPL29 | DQTKAQAAAPAsVPAQAPKRtQAPtKAsE____________ |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P48739 | S165 | Sugiyama | PITPNB | DRSQVEPADyKADEDPALFQsVKtKRGPLGPNWKKELANsP |
| P48741 | T49 | Sugiyama | HSPA7 HSP70B | EILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHNtV |
| P49327 | T1999 | Sugiyama | FASN FAS | LLENQTPEFFQDVCKPKYsGtLNLDRVTREACPELDYFVVF |
| P49368 | T373 | Sugiyama | CCT3 CCTG TRIC5 | KKIGDEYFTFITDCKDPKACtILLRGAsKEILSEVERNLQD |
| P49368 | T430 | Sugiyama | CCT3 CCTG TRIC5 | GGGASEMAVAHALTEKSKAMtGVEQWPyRAVAQALEVIPRT |
| P49368 | T459 | Sugiyama | CCT3 CCTG TRIC5 | AVAQALEVIPRTLIQNCGAstIRLLtSLRAKHtQENCEtWG |
| P49368 | T471 | Sugiyama | CCT3 CCTG TRIC5 | LIQNCGAstIRLLtSLRAKHtQENCEtWGVNGEtGtLVDMK |
| P49368 | T477 | Sugiyama | CCT3 CCTG TRIC5 | AstIRLLtSLRAKHtQENCEtWGVNGEtGtLVDMKELGIWE |
| P49368 | T486 | Sugiyama | CCT3 CCTG TRIC5 | LRAKHtQENCEtWGVNGEtGtLVDMKELGIWEPLAVKLQTY |
| P49411 | T433 | Sugiyama | TUFM | LRQPMILEKGQRFTLRDGNRtIGTGLVTNTLAMTEEEKNIK |
| P49588 | S627 | Sugiyama | AARS1 AARS | ATHILNFALRSVLGEADQKGsLVAPDRLRFDFTAKGAMSTQ |
| P49589 | S34 | Sugiyama | CARS1 CARS | VQPQWsPPAGtQPCRLHLyNsLtRNKEVFIPQDGKKVTWYC |
| P49591 | S298 | Sugiyama | SARS1 SARS SERS | ALHRDEWLRPEDLPIKyAGLsTCFRQEVGSHGRDTRGIFRV |
| P49792 | T1839 | Sugiyama | RANBP2 NUP358 | sAFTLGSEMKLHDssGsQVGtGFKSNFSEKASKFGNTEQGF |
| P50395 | S213 | Sugiyama | GDI2 RABGDIB | RtDDyLDQPCyEtINRIKLYsEsLARYGKsPYLyPLyGLGE |
| P50395 | T205 | Sugiyama | GDI2 RABGDIB | TGHALALYRtDDyLDQPCyEtINRIKLYsEsLARYGKsPYL |
| P50897 | S249 | Sugiyama | PPT1 CLN1 PPT | KFLNDSIVDPVDSEWFGFYRsGQAKEtIPLQEtsLytQDRL |
| P50897 | T255 | Sugiyama | PPT1 CLN1 PPT | IVDPVDSEWFGFYRsGQAKEtIPLQEtsLytQDRLGLKEMD |
| P50897 | T265 | Sugiyama | PPT1 CLN1 PPT | GFYRsGQAKEtIPLQEtsLytQDRLGLKEMDNAGQLVFLAT |
| P50897 | Y264 | Sugiyama | PPT1 CLN1 PPT | FGFYRsGQAKEtIPLQEtsLytQDRLGLKEMDNAGQLVFLA |
| P50914 | T43 | Sugiyama | RPL14 | KLVAIVDVIDQNRALVDGPCtQVRRQAMPFKCMQLTDFILK |
| P50990 | S161 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | EILPNLVCCsAKNLRDIDEVssLLRTSIMSKQyGNEVFLAK |
| P50990 | T374 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | EVGDTQVVVFKHEKEDGAIstIVLRGstDNLMDDIERAVDD |
| P50991 | T50 | Sugiyama | CCT4 CCTD SRB | PAQIRFsNISAAKAVADAIRtsLGPKGMDKMIQDGKGDVtI |
| P50991 | T69 | Sugiyama | CCT4 CCTD SRB | RtsLGPKGMDKMIQDGKGDVtItNDGAtILKQMQVLHPAAR |
| P50991 | T76 | Sugiyama | CCT4 CCTD SRB | GMDKMIQDGKGDVtItNDGAtILKQMQVLHPAARMLVELSK |
| P51149 | T168 | Sugiyama | RAB7A RAB7 | NIPyFEtSAKEAINVEQAFQtIARNALKQETEVELyNEFPE |
| P51153 | S164 | Sugiyama | RAB13 GIG4 | GIRFFETSAKSsMNVDEAFSsLARDILLKSGGRRsGNGNKP |
| P51858 | T184 | Sugiyama | HDGF HMG1L2 | DsPKRPKEAENPEGEEKEAAtLEVERPLPMEVEKNstPsEP |
| P51858 | T94 | Sugiyama | HDGF HMG1L2 | GKPNKRKGFsEGLWEIENNPtVKASGYQSsQKKsCVEEPEP |
| P51991 | S370 | Sugiyama | HNRNPA3 HNRPA3 | sFGGRssGsPyGGGyGsGGGsGGyGsRRF____________ |
| P52272 | S365 | Sugiyama | HNRNPM HNRPM NAGR1 | KMGGMEGPFGGGMENMGRFGsGMNMGRINEILsNALKRGEI |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T38 | Sugiyama | HSPA2 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P54652 | T46 | Sugiyama | HSPA2 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTN |
| P54652 | T48 | Sugiyama | HSPA2 | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTNTI |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55036 | S358 | Sugiyama | PSMD4 MCB1 | VLENLPGVDPNNEAIRNAMGsLAsQATKDGKKDKKEEDKK_ |
| P55036 | S39 | Sugiyama | PSMD4 MCB1 | GDFLPTRLQAQQDAVNIVCHsKTRSNPENNVGLITLANDCE |
| P55060 | S931 | Sugiyama | CSE1L CAS XPO2 | KKEHDPVGQMVNNPKIHLAQsLHKLSTACPGRVPSMVSTSL |
| P55060 | T339 | Sugiyama | CSE1L CAS XPO2 | QFLASVCERPHYKNLFEDQNtLtsICEKVIVPNMEFRAADE |
| P55209 | S69 | Sugiyama | NAP1L1 NRP | LAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNLQVKCA |
| P56192 | S127 | Sugiyama | MARS1 MARS | GKKGEDVLGSVRRALTHIDHsLSRQNCPFLAGETESLADIV |
| P57721 | S139 | Sugiyama | PCBP3 PCBP3-OT1 PCBP3OT | MSNSPATSKPPVTLRLVVPAsQCGsLIGKGGSKIKEIREst |
| P57721 | S143 | Sugiyama | PCBP3 PCBP3-OT1 PCBP3OT | PATSKPPVTLRLVVPAsQCGsLIGKGGSKIKEIREstGAQV |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | T173 | Sugiyama | TPI1 TPI | DNVKDWSKVVLAyEPVWAIGtGKtATPQQAQEVHEKLRGWL |
| P60174 | T176 | Sugiyama | TPI1 TPI | KDWSKVVLAyEPVWAIGtGKtATPQQAQEVHEKLRGWLKsN |
| P60174 | T214 | Sugiyama | TPI1 TPI | KsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGG |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60174 | T28 | Sugiyama | TPI1 TPI | FVGGNWKMNGRKQsLGELIGtLNAAKVPADtEVVCAPPtAy |
| P60174 | T90 | Sugiyama | TPI1 TPI | VTNGAFtGEIsPGMIKDCGAtWVVLGHsERRHVFGEsDELI |
| P60660 | T103 | Sugiyama | MYL6 | QGtyEDyVEGLRVFDKEGNGtVMGAEIRHVLVtLGEKMTEE |
| P60660 | T85 | Sugiyama | MYL6 | LDFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVM |
| P60709 | S239 | Sugiyama | ACTB | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | T106 | Sugiyama | ACTB | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P60709 | T201 | Sugiyama | ACTB | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P60709 | T203 | Sugiyama | ACTB | RDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALDF |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | T297 | Sugiyama | ACTB | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P60709 | T303 | Sugiyama | ACTB | MKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPs |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60842 | T80 | Sugiyama | EIF4A1 DDX2A EIF4A | QRAILPCIKGyDVIAQAQsGtGKTATFAISILQQIELDLKA |
| P60953 | T115 | Sugiyama | CDC42 | EKWVPEITHHCPKTPFLLVGtQIDLRDDPStIEKLAKNKQK |
| P60953 | T125 | Sugiyama | CDC42 | CPKTPFLLVGtQIDLRDDPStIEKLAKNKQKPITPETAEKL |
| P61160 | T15 | Sugiyama | ACTR2 ARP2 | ______MDSQGRKVVVCDNGtGFVKCGYAGSNFPEHIFPAL |
| P61204 | S147 | Sugiyama | ARF3 | KQDLPNAMNAAEITDKLGLHsLRHRNWYIQATCATSGDGLY |
| P61247 | S237 | Sugiyama | RPS3A FTE1 MFTL | MLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGyE |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61254 | T93 | Sugiyama | RPL26 | VYRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDK |
| P61313 | S97 | Sugiyama | RPL15 EC45 TCBAP0781 | KGAtyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLN |
| P61353 | S34 | Sugiyama | RPL27 | LAGRYSGRKAVIVKNIDDGtsDRPysHALVAGIDRyPRKVT |
| P61353 | T33 | Sugiyama | RPL27 | VLAGRYSGRKAVIVKNIDDGtsDRPysHALVAGIDRyPRKV |
| P61353 | T94 | Sugiyama | RPL27 | VyNyNHLMPtRysVDIPLDKtVVNKDVFRDPALKRKARREA |
| P61513 | S21 | Sugiyama | RPL37A | MAKRTKKVGIVGKyGtRYGAsLRKMVKKIEISQHAKYTCSF |
| P61513 | Y14 | Sugiyama | RPL37A | _______MAKRTKKVGIVGKyGtRYGAsLRKMVKKIEISQH |
| P61586 | T175 | Sugiyama | RHOA ARH12 ARHA RHO12 | GyMECsAKTKDGVREVFEMAtRAALQARRGKKKsGCLVL__ |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P62081 | T172 | Sugiyama | RPS7 | RLIKVHLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEF |
| P62191 | T56 | Sugiyama | PSMC1 | KKKKTKGPDAASKLPLVtPHtQCRLKLLKLERIKDYLLMEE |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62263 | S139 | Sugiyama | RPS14 PRO2640 | LARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL________ |
| P62263 | T140 | Sugiyama | RPS14 PRO2640 | ARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL_________ |
| P62266 | T34 | Sugiyama | RPS23 | RSHRRDQKWHDKQYKKAHLGtALKANPFGGAsHAKGIVLEK |
| P62273 | S9 | Sugiyama | RPS29 | ____________MGHQQLyWsHPRKFGQGSRSCRVCSNRHG |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62277 | T24 | Sugiyama | RPS13 | MHAPGKGLsQsALPyRRsVPtWLKLTsDDVKEQIyKLAKKG |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62280 | T28 | Sugiyama | RPS11 | RAyQKQPtIFQNKKRVLLGEtGKEKLPRYYKNIGLGFKtPK |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62316 | T40 | Sugiyama | SNRPD2 SNRPD1 | EEEEFNtGPLsVLtQsVKNNtQVLINCRNNKKLLGRVKAFD |
| P62424 | T84 | Sugiyama | RPL7A SURF-3 SURF3 | QRQRAILyKRLKVPPAINQFtQALDRQTAtQLLKLAHKYRP |
| P62495 | T298 | Sugiyama | ETF1 ERF1 RF1 SUP45L1 | VKFIQEKKLIGRyFDEIsQDtGKyCFGVEDTLKALEMGAVE |
| P62701 | S204 | Sugiyama | RPS4X CCG2 RPS4 SCAR | tGGANLGRIGVITNRERHPGsFDVVHVKDANGNSFATRLsN |
| P62701 | T247 | Sugiyama | RPS4X CCG2 RPS4 SCAR | VIGKGNKPWIsLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| P62736 | S241 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62750 | T126 | Sugiyama | RPL23A | KHQIKQAVKKLyDIDVAKVNtLIRPDGEKKAYVRLAPDyDA |
| P62753 | T127 | Sugiyama | RPS6 OK/SW-cl.2 | SVLNLVIVKKGEKDIPGLtDttVPRRLGPKRASRIRKLFNL |
| P62753 | T128 | Sugiyama | RPS6 OK/SW-cl.2 | VLNLVIVKKGEKDIPGLtDttVPRRLGPKRASRIRKLFNLs |
| P62753 | T34 | Sugiyama | RPS6 OK/SW-cl.2 | KLIEVDDERKLRtFyEKRMAtEVAADALGEEWKGYVVRIsG |
| P62826 | T21 | Sugiyama | RAN ARA24 OK/SW-cl.81 | MAAQGEPQVQFKLVLVGDGGtGKttFVKRHLtGEFEKKyVA |
| P62826 | T24 | Sugiyama | RAN ARA24 OK/SW-cl.81 | QGEPQVQFKLVLVGDGGtGKttFVKRHLtGEFEKKyVATLG |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62847 | S78 | Sugiyama | RPS24 | FGFRTHFGGGKttGFGMIyDsLDyAKKNEPKHRLARHGLYE |
| P62857 | T38 | Sugiyama | RPS28 | LGRtGsQGQCtQVRVEFMDDtsRsIIRNVKGPVREGDVLtL |
| P62857 | T57 | Sugiyama | RPS28 | DtsRsIIRNVKGPVREGDVLtLLEsEREARRLR________ |
| P62888 | S75 | Sugiyama | RPL30 | LRKsEIEyyAMLAKtGVHHysGNNIELGtACGKyyRVCtLA |
| P62899 | T113 | Sugiyama | RPL31 | NEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN________ |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62899 | Y108 | Sugiyama | RPL31 | LSRKRNEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN___ |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | T143 | Sugiyama | RPL8 | RGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVISSANR |
| P62942 | T15 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______MGVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGK |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P62942 | T28 | Sugiyama | FKBP1A FKBP1 FKBP12 | IsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPFK |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P62979 | S134 | Sugiyama | RPS27A UBA80 UBCEP1 | IsRLRRECPsDECGAGVFMAsHFDRHyCGKCCLtyCFNKPE |
| P62979 | T147 | Sugiyama | RPS27A UBA80 UBCEP1 | GAGVFMAsHFDRHyCGKCCLtyCFNKPEDK___________ |
| P63167 | T26 | Sugiyama | DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1 | AVIKNADMsEEMQQDsVECAtQALEKYNIEKDIAAHIKKEF |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63261 | S239 | Sugiyama | ACTG1 ACTG | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | T106 | Sugiyama | ACTG1 ACTG | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P63261 | T201 | Sugiyama | ACTG1 ACTG | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P63261 | T203 | Sugiyama | ACTG1 ACTG | RDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALDF |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | T297 | Sugiyama | ACTG1 ACTG | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P63261 | T303 | Sugiyama | ACTG1 ACTG | MKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPs |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63267 | S240 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P67809 | T89 | Sugiyama | YBX1 NSEP1 YB1 | RNGyGFINRNDtKEDVFVHQtAIKKNNPRKyLRsVGDGEtV |
| P68032 | S241 | Sugiyama | ACTC1 ACTC | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68104 | T261 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S241 | Sugiyama | ACTA1 ACTA | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68363 | T51 | Sugiyama | TUBA1B | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P68363 | T56 | Sugiyama | TUBA1B | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T80 | Sugiyama | TUBA1B | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| P68363 | T82 | Sugiyama | TUBA1B | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| P68363 | Y83 | Sugiyama | TUBA1B | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P68431 | T46 | Sugiyama | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| P78371 | S60 | Sugiyama | CCT2 99D8.1 CCTB | KSTLGPKGMDKILLsSGRDAsLMVtNDGAtILKNIGVDNPA |
| P78371 | T64 | Sugiyama | CCT2 99D8.1 CCTB | GPKGMDKILLsSGRDAsLMVtNDGAtILKNIGVDNPAAKVL |
| P78371 | T69 | Sugiyama | CCT2 99D8.1 CCTB | DKILLsSGRDAsLMVtNDGAtILKNIGVDNPAAKVLVDMSR |
| P78406 | T256 | Sugiyama | RAE1 MRNP41 | IEGRVAIHYINPPNPAKDNFtFKCHRSNGTNTSAPQDIyAV |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84077 | S147 | Sugiyama | ARF1 | KQDLPNAMNAAEITDKLGLHsLRHRNWYIQATCATSGDGLY |
| P84243 | T46 | Sugiyama | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | ARKsAPsTGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| P99999 | T50 | Sugiyama | CYCS CYC | GPNLHGLFGRKtGQAPGysytAANKNKGIIWGEDTLMEYLE |
| Q00535 | T14 | Sugiyama | CDK5 CDKN5 PSSALRE | _______MQKYEKLEKIGEGtyGtVFKAKNRETHEIVALKR |
| Q00535 | T17 | Sugiyama | CDK5 CDKN5 PSSALRE | ____MQKYEKLEKIGEGtyGtVFKAKNRETHEIVALKRVRL |
| Q00535 | Y15 | Sugiyama | CDK5 CDKN5 PSSALRE | ______MQKYEKLEKIGEGtyGtVFKAKNRETHEIVALKRV |
| Q00610 | S146 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | AVYHWSMEGESQPVKMFDRHssLAGCQIINYRTDAKQKWLL |
| Q00796 | S73 | Sugiyama | SORD | EYGRIGNFIVKKPMVLGHEAsGtVEKVGSSVKHLKPGDRVA |
| Q00796 | T75 | Sugiyama | SORD | GRIGNFIVKKPMVLGHEAsGtVEKVGSSVKHLKPGDRVAIE |
| Q00839 | T530 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | KTTWVTKHAAENPGKyNILGtNtIMDKMMVAGFKKQMADtG |
| Q00839 | T532 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | TWVTKHAAENPGKyNILGtNtIMDKMMVAGFKKQMADtGKL |
| Q00839 | T554 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | MDKMMVAGFKKQMADtGKLNtLLQRAPQCLGKFIEIAARKK |
| Q00839 | T582 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | CLGKFIEIAARKKRNFILDQtNVsAAAQRRKMCLFAGFQRK |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q01518 | T165 | Sugiyama | CAP1 CAP | AMAPKPGPYVKEMNDAAMFytNRVLKEYKDVDKKHVDWVKA |
| Q01518 | Y164 | Sugiyama | CAP1 CAP | VAMAPKPGPYVKEMNDAAMFytNRVLKEYKDVDKKHVDWVK |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q02543 | T101 | Sugiyama | RPL18A | WLRYDsRSGtHNMYREyRDLttAGAVtQCyRDMGARHRARA |
| Q02543 | T107 | Sugiyama | RPL18A | RSGtHNMYREyRDLttAGAVtQCyRDMGARHRARAHsIQIM |
| Q02543 | Y97 | Sugiyama | RPL18A | NFGIWLRYDsRSGtHNMYREyRDLttAGAVtQCyRDMGARH |
| Q02878 | S255 | Sugiyama | RPL6 TXREB1 | tEKEKYEITEQRKIDQKAVDsQILPKIKAIPQLQGYLRSVF |
| Q02878 | T235 | Sugiyama | RPL6 TXREB1 | AyFKKKKLRKPRHQEGEIFDtEKEKYEITEQRKIDQKAVDs |
| Q02878 | T91 | Sugiyama | RPL6 TXREB1 | RKYSAAKSKVEKKKKEKVLAtVtKPVGGDKNGGTRVVKLRK |
| Q05639 | T261 | Sugiyama | EEF1A2 EEF1AL STN | PTDKPLRLPLQDVyKIGGIGtVPVGRVETGILRPGMVVTFA |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q06830 | S152 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | IIDDKGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEV |
| Q06830 | T156 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | KGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEVCPAG |
| Q06830 | T166 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | DLPVGRsVDEtLRLVQAFQFtDKHGEVCPAGWKPGsDtIKP |
| Q06830 | T183 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | FQFtDKHGEVCPAGWKPGsDtIKPDVQKSKEyFSKQK____ |
| Q07020 | T136 | Sugiyama | RPL18 | AGGKILtFDQLALDsPKGCGtVLLsGPRKGREVYRHFGKAP |
| Q07020 | T42 | Sugiyama | RPL18 | DIyLRLLVKLYRFLARRtNstFNQVVLKRLFMSRtNRPPLs |
| Q07020 | T85 | Sugiyama | RPL18 | RMIRKMKLPGRENKtAVVVGtItDDVRVQEVPKLKVCALRV |
| Q07157 | T1167 | Sugiyama | TJP1 ZO1 | EQAPRAsALRHEEQPAPGyDtHGRLRPEAQPHPsAGPKPAE |
| Q08043 | T354 | Sugiyama | ACTN3 | RRLHKPPRIQEKCQLEINFNtLQtKLRLSHRPAFMPSEGKL |
| Q08043 | T357 | Sugiyama | ACTN3 | HKPPRIQEKCQLEINFNtLQtKLRLSHRPAFMPSEGKLVSD |
| Q12965 | T945 | Sugiyama | MYO1E MYO1C | PKNSRPTRRNttQNtGySsGtQNANyPVRAAPPPPGyHQNG |
| Q13085 | T833 | Sugiyama | ACACA ACAC ACC1 ACCA | CVLAKMQLDNPSKVQQAELHtGsLPRIQSTALRGEKLHRVF |
| Q13162 | S73 | Sugiyama | PRDX4 | FyAGGQVyPGEAsRVsVADHsLHLSKAKISKPAPYWEGTAV |
| Q13200 | T709 | Sugiyama | PSMD2 TRAP2 | AVPLALALISVSNPRLNILDtLSKFSHDADPEVSYNSIFAM |
| Q13310 | T191 | Sugiyama | PABPC4 APP1 PABP4 | GRFKSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELF |
| Q13347 | T218 | Sugiyama | EIF3I EIF3S2 TRIP1 | RDMtMFVtASKDNTAKLFDsttLEHQKTFRTERPVNSAALs |
| Q13347 | T219 | Sugiyama | EIF3I EIF3S2 TRIP1 | DMtMFVtASKDNTAKLFDsttLEHQKTFRTERPVNSAALsP |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13509 | T72 | Sugiyama | TUBB3 TUBB4 | NEASSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIF |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q13885 | T72 | Sugiyama | TUBB2A TUBB2 | NEAAGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q14103 | S271 | Sugiyama | HNRNPD AUF1 HNRPD | KCEIKVAMSKEQyQQQQQWGsRGGFAGRARGRGGGPSQNWN |
| Q14152 | S1028 | Sugiyama | EIF3A EIF3S10 KIAA0139 | NWRHADDDRPPRRGLDEDRGsWRtADEDRGPRRGMDDDRGP |
| Q14152 | S1258 | Sugiyama | EIF3A EIF3S10 KIAA0139 | RFRRPRDEGGWRRGPAEEsssWRDssRRDDRDRDDRRRERD |
| Q14152 | S1262 | Sugiyama | EIF3A EIF3S10 KIAA0139 | PRDEGGWRRGPAEEsssWRDssRRDDRDRDDRRRERDDRRD |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14152 | T1379 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EKDREsLRRTKNEtDEDGWttVRR_________________ |
| Q14152 | T735 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EEQRIKDMDLWEQQEEERIttMQLEREKALEHKNRMSRMLE |
| Q14232 | T212 | Sugiyama | EIF2B1 EIF2BA | LVIVGAEGVVENGGIINKIGtNQMAVCAKAQNKPFYVVAES |
| Q14240 | T81 | Sugiyama | EIF4A2 DDX2B EIF4F | QRAIIPCIKGyDVIAQAQsGtGKTATFAISILQQLEIEFKE |
| Q14247 | T68 | Sugiyama | CTTN EMS1 | GHQEHINIHKLRENVFQEHQtLKEKELETGPKASHGyGGKF |
| Q14566 | T195 | Sugiyama | MCM6 | TQPNICRNPVCANRRRFLLDtNKSRFVDFQKVRIQETQAEL |
| Q14568 | S165 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTK |
| Q14677 | S166 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | REERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDE |
| Q14683 | T1005 | Sugiyama | SMC1A DXS423E KIAA0178 SB1.8 SMC1 SMC1L1 | DLCEDLKDAQAEEEIKQEMNtLQQKLNEQQsVLQRIAAPNM |
| Q14684 | S422 | Sugiyama | RRP1B KIAA0179 | KKKKKHHLQPENPGPGGAAPsLEQNRGREPEASGLKALKAR |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15084 | S389 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | FALLKGsFsEQGINEFLRELsFGRGstAPVGGGAFPtIVER |
| Q15084 | T100 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | AVDADKHHsLGGQyGVQGFPtIKIFGSNKNRPEDYQGGRTG |
| Q15084 | T239 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | AVDAtVNQVLAsRYGIRGFPtIKIFQKGEsPVDyDGGRTRs |
| Q15084 | Y93 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | KDVVKVGAVDADKHHsLGGQyGVQGFPtIKIFGSNKNRPED |
| Q15185 | S72 | Sugiyama | PTGES3 P23 TEBP | EIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQsWPRLTKE |
| Q15185 | S85 | Sugiyama | PTGES3 P23 TEBP | KHKRtDRsILCCLRKGEsGQsWPRLTKERAKLNWLsVDFNN |
| Q15293 | T100 | Sugiyama | RCN1 RCN | sKERLGKIVDRIDNDGDGFVttEELKtWIKRVQKRyIFDNV |
| Q15293 | T106 | Sugiyama | RCN1 RCN | KIVDRIDNDGDGFVttEELKtWIKRVQKRyIFDNVAKVWKD |
| Q15293 | T211 | Sugiyama | RCN1 RCN | FTAFLHPEEFEHMKEIVVLEtLEDIDKNGDGFVDQDEyIAD |
| Q15365 | S111 | Sugiyama | PCBP1 | TAASRPPVTLRLVVPATQCGsLIGKGGCKIKEIREstGAQV |
| Q15366 | S107 | Sugiyama | PCBP2 | MTNstAASRPPVTLRLVVPAsQCGsLIGKGGCKIKEIREst |
| Q15366 | S111 | Sugiyama | PCBP2 | tAASRPPVTLRLVVPAsQCGsLIGKGGCKIKEIREstGAQV |
| Q15459 | S506 | Sugiyama | SF3A1 SAP114 | KKIGEEEIQKPEEKVTWDGHsGsMARTQQAAQANITLQEQI |
| Q15459 | S508 | Sugiyama | SF3A1 SAP114 | IGEEEIQKPEEKVTWDGHsGsMARTQQAAQANITLQEQIEA |
| Q15691 | S140 | Sugiyama | MAPRE1 | DGKDyDPVAARQGQEtAVAPsLVAPALNKPKKPLtsssAAP |
| Q15691 | T135 | Sugiyama | MAPRE1 | FDANyDGKDyDPVAARQGQEtAVAPsLVAPALNKPKKPLts |
| Q15797 | T322 | GPS6|SIGNOR|PSP | SMAD1 BSP1 MADH1 MADR1 | PSNNKNRFCLGLLsNVNRNstIENTRRHIGKGVHLYYVGGE |
| Q16576 | T10 | Sugiyama | RBBP7 RBAP46 | ___________MAsKEMFEDtVEERVINEEYKIWKKNTPFL |
| Q16658 | S237 | Sugiyama | FSCN1 FAN1 HSN SNL | RsGKVAFRDCEGRyLAPsGPsGtLKAGKATKVGKDELFALE |
| Q16658 | T125 | Sugiyama | FSCN1 FAN1 HSN SNL | SEAHRRYFGGtEDRLsCFAQtVsPAEKWSVHIAMHPQVNIY |
| Q16658 | T79 | Sugiyama | FSCN1 FAN1 HSN SNL | AVCLRSHLGRyLAADKDGNVtCEREVPGPDCRFLIVAHDDG |
| Q16695 | T46 | Sugiyama | H3-4 H3FT HIST3H3 | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q16775 | T292 | Sugiyama | HAGH GLO2 HAGH1 | FMRVREKTVQQHAGETDPVttMRAVRREKDQFKMPRD____ |
| Q2VIR3 | T22 | Sugiyama | EIF2S3B | AGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAtI |
| Q2VIR3 | T41 | Sugiyama | EIF2S3B | ttLDVtKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAI |
| Q2VIR3 | T46 | Sugiyama | EIF2S3B | tKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAISGVHT |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q3ZCM7 | S75 | Sugiyama | TUBB8 | SGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIFGQC |
| Q3ZCM7 | T72 | Sugiyama | TUBB8 | NEASGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIF |
| Q562R1 | S240 | Sugiyama | ACTBL2 | VALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPE |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q58FF6 | S34 | Sugiyama | HSP90AB4P | IFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPN |
| Q58FF6 | T36 | Sugiyama | HSP90AB4P | LQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPNPR |
| Q58FF7 | S488 | Sugiyama | HSP90AB3P HSP90BC | TYGWTANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIM |
| Q58FF7 | S58 | Sugiyama | HSP90AB3P HSP90BC | IFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF7 | S67 | Sugiyama | HSP90AB3P HSP90BC | ASDALDKIRyEsLtDPsKLDsGKELKIDIIPNPQERTLALV |
| Q58FF7 | T489 | Sugiyama | HSP90AB3P HSP90BC | YGWTANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIME |
| Q58FF7 | T60 | Sugiyama | HSP90AB3P HSP90BC | LQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPNPQ |
| Q58FF7 | Y56 | Sugiyama | HSP90AB3P HSP90BC | EEIFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FF8 | S58 | Sugiyama | HSP90AB2P HSP90BB | IFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | S67 | Sugiyama | HSP90AB2P HSP90BB | ASDALDKIRyEsLtDPsKLDsGKELKIDIIPNTQEHTLTLV |
| Q58FF8 | T60 | Sugiyama | HSP90AB2P HSP90BB | LWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPNTQ |
| Q58FF8 | Y56 | Sugiyama | HSP90AB2P HSP90BB | KEIFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FG0 | T180 | Sugiyama | HSP90AA5P HSP90AE | EELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQKHG |
| Q58FG1 | T28 | Sugiyama | HSP90AA4P HSP90AD HSPCAL2 | SKLDSGKEPHISLIPNKQDRtLtIVDtGIGMTKADLINNLG |
| Q58FG1 | T34 | Sugiyama | HSP90AA4P HSP90AD HSPCAL2 | KEPHISLIPNKQDRtLtIVDtGIGMTKADLINNLGTITKSE |
| Q5JSH3 | S667 | Sugiyama | WDR44 RPH11 | IDFVTAIAFHPRDDRYFLSGsLDGKLRLWNIPDKKVALWNE |
| Q5VTE0 | T261 | Sugiyama | EEF1A1P5 EEF1AL3 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q6NXT2 | T45 | Sugiyama | H3-5 H3F3C | AARKSTPSTCGVKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q6P996 | T687 | Sugiyama | PDXDC1 KIAA0251 | AGsLESTEPIyVYKAQGAGVtLPPtPsGsRtKQRLPGQKPF |
| Q6P996 | T697 | Sugiyama | PDXDC1 KIAA0251 | yVYKAQGAGVtLPPtPsGsRtKQRLPGQKPFKRsLRGsDAL |
| Q6PEY2 | T51 | Sugiyama | TUBA3E | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q6PEY2 | T56 | Sugiyama | TUBA3E | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVVD |
| Q6S8J3 | S939 | Sugiyama | POTEE A26C1A POTE2 | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q6UXH1 | T300 | Sugiyama | CRELD2 UNQ185/PRO211 | GYAREHGQCADVDECsLAEKtCVRKNENCYNTPGSYVCVCP |
| Q6XQN6 | S500 | Sugiyama | NAPRT FHIP NAPRT1 | QGQLCEPLPSLAESRALAQLsLSRLSPEHRRLRsPAQYQVV |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZMR3 | S167 | Sugiyama | LDHAL6A LDHL2 | AWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIHSESCHG |
| Q71DI3 | T46 | Sugiyama | H3C15 HIST2H3A; H3C14 H3F2 H3FM HIST2H3C; H3C13 HIST2H3D | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q71U36 | T51 | Sugiyama | TUBA1A TUBA3 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q71U36 | T56 | Sugiyama | TUBA1A TUBA3 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T80 | Sugiyama | TUBA1A TUBA3 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q71U36 | T82 | Sugiyama | TUBA1A TUBA3 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q71U36 | Y83 | Sugiyama | TUBA1A TUBA3 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7KZF4 | S52 | Sugiyama | SND1 TDRD11 | AIIVRGQPRGGPPPERQINLsNIRAGNLARRAAATQPDAKD |
| Q7L014 | T885 | Sugiyama | DDX46 KIAA0801 | LGIESQDVMQQATNAILRGGtILAPtVsAKTIAEQLAEKIN |
| Q7L014 | T890 | Sugiyama | DDX46 KIAA0801 | QDVMQQATNAILRGGtILAPtVsAKTIAEQLAEKINAKLNy |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86UE4 | T477 | Sugiyama | MTDH AEG1 LYRIC | stAQDtEELEKEIREDLPVNtsKTRPKQEKAFSLKtIstsD |
| Q86VP6 | T572 | Sugiyama | CAND1 KIAA0829 TIP120 TIP120A | PLDQPssFDAtPYIKDLFTCtIKRLKAADIDQEVKERAISC |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8N0Y7 | T96 | Sugiyama | PGAM4 PGAM3 | QMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQVKIWR |
| Q8N1G4 | T374 | Sugiyama | LRRC47 KIAA1185 | RFLTSQTKLHEDLCEKRtAAtLAtHELRAVKGPLLYCARPP |
| Q8N1G4 | T377 | Sugiyama | LRRC47 KIAA1185 | TSQTKLHEDLCEKRtAAtLAtHELRAVKGPLLYCARPPQDL |
| Q8N6M0 | T128 | Sugiyama | OTUD6B DUBA5 CGI-77 | KAALEKEREERIAEAEIENLtGARHMESEKLAQILAARQLE |
| Q8N6T3 | T292 | Sugiyama | ARFGAP1 ARF1GAP | VsQLAsKVQGVGSKGWRDVttFFsGKAEGPLDsPSEGHSyQ |
| Q8N8S7 | T74 | Sugiyama | ENAH MENA | QDHQVVINCAIPKGLKYNQAtQtFHQWRDARQVyGLNFGSK |
| Q8N8S7 | T76 | Sugiyama | ENAH MENA | HQVVINCAIPKGLKYNQAtQtFHQWRDARQVyGLNFGSKED |
| Q8NBJ7 | T260 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | SPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMGNtPD |
| Q8NBP7 | S487 | Sugiyama | PCSK9 NARC1 PSEC0052 | PTRMATAVARCAPDEELLsCssFSRSGKRRGERMEAQGGKL |
| Q8NHW5 | T128 | Sugiyama | RPLP0P6 | PAAARAGAIAPCEVtVPAQNtGLGPEKTSFFQALGItTKIS |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8TD47 | T247 | Sugiyama | RPS4Y2 RPS4Y2P | VIGNGNKPWISLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| Q8WU90 | S351 | Sugiyama | ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 | DIDLSLYIPRDVDEtGItVAsLERFSTYTsDKDENKLsEAs |
| Q92598 | S65 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | NRTIGVAAKNQQITHANNtVsNFKRFHGRAFNDPFIQKEKE |
| Q92598 | T63 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | SKNRTIGVAAKNQQITHANNtVsNFKRFHGRAFNDPFIQKE |
| Q92890 | S299 | Sugiyama | UFD1 UFD1L | KKVEEDEAGGRFVAFsGEGQsLRKKGRKP____________ |
| Q96AY3 | T200 | Sugiyama | FKBP10 FKBP65 PSEC0056 | HYNGTLLDGTSFDTSYSKGGtyDtyVGsGWLIKGMDQGLLG |
| Q96AY3 | T203 | Sugiyama | FKBP10 FKBP65 PSEC0056 | GTLLDGTSFDTSYSKGGtyDtyVGsGWLIKGMDQGLLGMCP |
| Q96G46 | T99 | Sugiyama | DUS3L | DGQtADGQtEEAAEPGEQLQtQKRARGQNKGRPHVKPTNYD |
| Q96MT3 | T370 | SIGNOR | PRICKLE1 RILP | LLLsPALNYKFPGLSGNADDtLSRKLDDLsLSRQGTSFASE |
| Q96QK1 | T773 | Sugiyama | VPS35 MEM3 TCCCTA00141 | DLPNLEssEEtEQINKHFHNtLEHLRLRREsPEsEGPIyEG |
| Q96RE7 | T465 | Sugiyama | NACC1 BTBD14B NAC1 | QNFAPNFKESEMNAIAADMCtNARRVVRKSWMPKVKVLKAE |
| Q99426 | T120 | Sugiyama | TBCB CG22 CKAP1 | DVSRVEKytIsQEAyDQRQDtVRSFLKRsKLGRyNEEERAQ |
| Q99575 | S127 | Sugiyama | POP1 KIAA0061 | FAQARAAEISAMLKAVTQKssNsLVFQtLPRHMRRRAMSHN |
| Q99575 | T134 | Sugiyama | POP1 KIAA0061 | EISAMLKAVTQKssNsLVFQtLPRHMRRRAMSHNVKRLPRR |
| Q99613 | T880 | Sugiyama | EIF3C EIF3S8 | AEKLGsLVENNERVFDHKQGtyGGyFRDQKDGYRKNEGYMR |
| Q99615 | T52 | Sugiyama | DNAJC7 TPR2 TTC2 | KEQGNAYYAKKDYNEAyNyytKAIDMCPKNASYYGNRAATL |
| Q99729 | S242 | Sugiyama | HNRNPAB ABBP1 HNRPAB | SKCEIKVAQPKEVyQQQQyGsGGRGNRNRGNRGSGGGGGGG |
| Q99798 | T415 | Sugiyama | ACO2 | RSAAVAKQALAHGLKCKSQFtITPGSEQIRAtIERDGyAQI |
| Q99798 | T426 | Sugiyama | ACO2 | HGLKCKSQFtITPGSEQIRAtIERDGyAQILRDLGGIVLAN |
| Q99832 | T57 | Sugiyama | CCT7 CCTH NIP7-1 | RTTLGPRGMDKLIVDGRGKAtIsNDGAtILKLLDVVHPAAK |
| Q99832 | T64 | Sugiyama | CCT7 CCTH NIP7-1 | GMDKLIVDGRGKAtIsNDGAtILKLLDVVHPAAKTLVDIAK |
| Q9BQE3 | T51 | Sugiyama | TUBA1C TUBA6 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q9BQE3 | T56 | Sugiyama | TUBA1C TUBA6 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T80 | Sugiyama | TUBA1C TUBA6 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q9BQE3 | T82 | Sugiyama | TUBA1C TUBA6 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q9BQE3 | Y83 | Sugiyama | TUBA1C TUBA6 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q9BS26 | T155 | Sugiyama | ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075 | yIRQQKSDPIQEIRDLAEIttLDRSKRNIIGYFEQKDSDNy |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BVA1 | T72 | Sugiyama | TUBB2B | NEAtGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q9BXP5 | T705 | Sugiyama | SRRT ARS2 ASR2 | AQKMGRKDPEQEVEKFVtsNtQELGKDKWLCPLsGKKFKGP |
| Q9BYX7 | S239 | Sugiyama | POTEKP ACTBL3 FKSG30 | VALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPE |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9H0C5 | S273 | Sugiyama | BTBD1 C15orf1 NS5ATP8 | QRQQLPVTFGNKQKVLGKALsLIRFPLMTIEEFAAGPAQSG |
| Q9H3K6 | T27 | Sugiyama | BOLA2 BOLA2A My016; BOLA2B | YLREKLQRDLEAEHVEVEDttLNRCsCsFRVLVVSAKFEGK |
| Q9H788 | S124 | Sugiyama | SH2D4A PPP1R38 SH2A | LKAEQEAEEPRKTHsEEFTNsLKTKsQyHDLQAPDNQQtKD |
| Q9H788 | S187 | Sugiyama | SH2D4A PPP1R38 SH2A | EEKIRSLSSSSRNIQQMLADsINRMKAYAFHQKKESMKKKQ |
| Q9HDC9 | T131 | Sugiyama | APMAP C20orf3 UNQ1869/PRO4305 | VMFTGTADGRVVKLENGEIEtIARFGSGPCKTRDDEPVCGR |
| Q9NR45 | S251 | Sugiyama | NANS SAS | GAKVLERHITLDKTWKGsDHsAsLEPGELAELVRSVRLVER |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NTZ6 | T407 | Sugiyama | RBM12 KIAA0765 HRIHFB2091 | GHITFKQNMGPSGQTHPPPQtLPRSKsPsGQKRsRsRsPHE |
| Q9NXH9 | T613 | Sugiyama | TRMT1 | DVAQRAARLKTFPCKRFKEGtCQRGDQCCYsHsPPtPRVSA |
| Q9NY33 | T198 | Sugiyama | DPP3 | MEDAKLAQDFLDsQNLsAyNtRLFKEVDGEGKPYYEVRLAs |
| Q9P0J1 | T494 | Sugiyama | PDP1 PDP PPM2C | EDQNAATHLIRHAVGNNEFGtVDHERLSKMLSLPEELARMY |
| Q9P258 | T20 | Sugiyama | RCC2 KIAA1470 TD60 | _MPRKKAAAAAWEEPssGNGtARAGPRKRGGPAGRKRERPE |
| Q9P2J5 | T721 | Sugiyama | LARS1 KIAA1352 LARS | PTAVRANGHLLLNSEKMSKstGNFLtLtQAIDKFSADGMRL |
| Q9P2J5 | T726 | Sugiyama | LARS1 KIAA1352 LARS | ANGHLLLNSEKMSKstGNFLtLtQAIDKFSADGMRLALADA |
| Q9UBT2 | T268 | Sugiyama | UBA2 SAE2 UBLE1B HRIHFB2115 | GYDPVKLFTKLFKDDIRYLLtMDKLWRKRKPPVPLDWAEVQ |
| Q9UI15 | T190 | Sugiyama | TAGLN3 NP25 | GQNVIGLQMGSNKGAsQAGMtGyGMPRQIM___________ |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UNX3 | T93 | Sugiyama | RPL26L1 RPL26P1 | VYRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDK |
| Q9UPQ0 | S204 | Sugiyama | LIMCH1 KIAA1102 | DsERsDsLsPPRHGRDDsFDsLDsFGsRsRQtPsPDVVLRG |
| Q9UPU5 | T2565 | Sugiyama | USP24 KIAA1057 | NVSNETsTGKTFQRtIsAQDtLAyAtALLNEKEQSGSSNGS |
| Q9UPU5 | T2570 | Sugiyama | USP24 KIAA1057 | TsTGKTFQRtIsAQDtLAyAtALLNEKEQSGSSNGSEssPA |
| Q9UQ80 | T200 | Sugiyama | PA2G4 EBP1 | TPIEGMLSHQLKQHVIDGEKtIIQNPTDQQKKDHEKAEFEV |
| Q9UQ80 | T386 | Sugiyama | PA2G4 EBP1 | tQKKKKKKAsKtAENAtsGEtLEENEAGD____________ |
| Q9Y281 | T91 | Sugiyama | CFL2 | FVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWAPESAPL |
| Q9Y281 | Y89 | Sugiyama | CFL2 | tsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| Q9Y295 | T62 | Sugiyama | DRG1 NEDD3 | LITPKGGGGGGPGEGFDVAKtGDARIGFVGFPSVGKSTLLS |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2T7 | T124 | Sugiyama | YBX2 CSDA3 MSY2 | RNGyGFINRNDtKEDVFVHQtAIKRNNPRKFLRsVGDGEtV |
| Q9Y2T7 | T143 | Sugiyama | YBX2 CSDA3 MSY2 | QtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEATNVTGP |
| Q9Y2W1 | T227 | Sugiyama | THRAP3 BCLAF2 TRAP150 | sGGtsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRER |
| Q9Y2W1 | T230 | Sugiyama | THRAP3 BCLAF2 TRAP150 | tsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERsPA |
| Q9Y2W1 | Y228 | Sugiyama | THRAP3 BCLAF2 TRAP150 | GGtsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERs |
| Q9Y383 | S347 | Sugiyama | LUC7L2 CGI-59 CGI-74 | SRERSKRRSSKERFRDQDLAsCDRDRssRDRSPRDRDRKDK |
| Q9Y3A5 | T113 | Sugiyama | SBDS CGI-97 | VQVSDKERHTQLEQMFRDIAtIVADKCVNPETKRPYtVILI |
| Q9Y3F4 | S230 | Sugiyama | STRAP MAWD UNRIP | SAVSLDPIKsFEAPAtINsAsLHPEKEFLVAGGEDFKLyKy |
| Q9Y3F4 | T117 | Sugiyama | STRAP MAWD UNRIP | LAHKHIVKtVDFtQDSNyLLtGGQDKLLRIYDLNKPEAEPK |
| Q9Y3F4 | T225 | Sugiyama | STRAP MAWD UNRIP | SIAFHSAVSLDPIKsFEAPAtINsAsLHPEKEFLVAGGEDF |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y4L1 | S461 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | VVYPILVEFTREVEEEPGIHsLKHNKRVLFSRMGPYPQRKV |
| Q9Y4L1 | S742 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | KLQDLTLRDLEKQEREKAANsLEAFIFEtQDKLyQPEyQEV |
| Q9Y4L1 | T750 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | DLEKQEREKAANsLEAFIFEtQDKLyQPEyQEVsTEEQREE |
| Q9Y5L4 | S57 | Sugiyama | TIMM13 TIM13B TIMM13A TIMM13B | ELLQRMTDKCFRKCIGKPGGsLDNSEQKCIAMCMDRyMDAW |
| Q9Y5L4 | T79 | Sugiyama | TIMM13 TIM13B TIMM13A TIMM13B | DNSEQKCIAMCMDRyMDAWNtVsRAYNSRLQRERANM____ |
| Q9Y5S2 | S853 | Sugiyama | CDC42BPB KIAA1124 | GYLQALASKMTEELEALRsSsLGSRtLDPLWKVRRsQKLDM |
| Q9Y5S2 | T858 | Sugiyama | CDC42BPB KIAA1124 | LASKMTEELEALRsSsLGSRtLDPLWKVRRsQKLDMSARLE |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signal Transduction | R-HSA-162582 | 2.224881e-09 | 8.653 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 4.736008e-08 | 7.325 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 7.836301e-08 | 7.106 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 8.971113e-08 | 7.047 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.866995e-07 | 6.543 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.924119e-06 | 5.716 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.961559e-06 | 5.528 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 7.177510e-06 | 5.144 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.815726e-05 | 4.741 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.151239e-05 | 4.667 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 2.711085e-05 | 4.567 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.583105e-05 | 4.446 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.587192e-05 | 4.338 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 6.019959e-05 | 4.220 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 6.019959e-05 | 4.220 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 6.019959e-05 | 4.220 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 6.019959e-05 | 4.220 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 6.245992e-05 | 4.204 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 6.638198e-05 | 4.178 | 0 | 0 |
| Kinesins | R-HSA-983189 | 8.621171e-05 | 4.064 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 9.547526e-05 | 4.020 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 9.547526e-05 | 4.020 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 9.433062e-05 | 4.025 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.086707e-04 | 3.964 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.149894e-04 | 3.939 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.251527e-04 | 3.903 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.254950e-04 | 3.901 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.316593e-04 | 3.881 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.348853e-04 | 3.870 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.478640e-04 | 3.830 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.478640e-04 | 3.830 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.478640e-04 | 3.830 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.932579e-04 | 3.714 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.074241e-04 | 3.683 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 2.390821e-04 | 3.621 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.352929e-04 | 3.628 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.352929e-04 | 3.628 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.431379e-04 | 3.614 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.893623e-04 | 3.539 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.852136e-04 | 3.545 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.934897e-04 | 3.532 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.086494e-04 | 3.511 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.074174e-04 | 3.512 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.257836e-04 | 3.487 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.420582e-04 | 3.466 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.491897e-04 | 3.457 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 4.072353e-04 | 3.390 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.335590e-04 | 3.363 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 4.754691e-04 | 3.323 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.575175e-04 | 3.340 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 4.754691e-04 | 3.323 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.828271e-04 | 3.316 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 5.414496e-04 | 3.266 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 6.062191e-04 | 3.217 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.373420e-04 | 3.132 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 7.451314e-04 | 3.128 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.824883e-04 | 3.107 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 8.737020e-04 | 3.059 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 9.365000e-04 | 3.028 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 9.365000e-04 | 3.028 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.039488e-04 | 3.044 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 9.447635e-04 | 3.025 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.019151e-03 | 2.992 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.026905e-03 | 2.988 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.065712e-03 | 2.972 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.069334e-03 | 2.971 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.306529e-03 | 2.884 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.445448e-03 | 2.840 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.451254e-03 | 2.838 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 1.478524e-03 | 2.830 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.604175e-03 | 2.795 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.817747e-03 | 2.740 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.997785e-03 | 2.699 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.997785e-03 | 2.699 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.246949e-03 | 2.648 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.346746e-03 | 2.630 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.355683e-03 | 2.628 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.600978e-03 | 2.585 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.687474e-03 | 2.571 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.710850e-03 | 2.567 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.005493e-03 | 2.522 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.983518e-03 | 2.525 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.064260e-03 | 2.514 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.308370e-03 | 2.480 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.369912e-03 | 2.472 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.639440e-03 | 2.439 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.639440e-03 | 2.439 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.837245e-03 | 2.416 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 4.553961e-03 | 2.342 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 4.625159e-03 | 2.335 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.910748e-03 | 2.309 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 5.555379e-03 | 2.255 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 6.617084e-03 | 2.179 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 6.688562e-03 | 2.175 | 0 | 0 |
| Protein folding | R-HSA-391251 | 6.944540e-03 | 2.158 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 7.090539e-03 | 2.149 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 7.816814e-03 | 2.107 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 7.191386e-03 | 2.143 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 7.858818e-03 | 2.105 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 9.175922e-03 | 2.037 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 9.175922e-03 | 2.037 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 9.175922e-03 | 2.037 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 9.175922e-03 | 2.037 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.304363e-03 | 2.031 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 9.304363e-03 | 2.031 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 9.361046e-03 | 2.029 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 9.461206e-03 | 2.024 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.066258e-02 | 1.972 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.066258e-02 | 1.972 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.066258e-02 | 1.972 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.066258e-02 | 1.972 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.066258e-02 | 1.972 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.066258e-02 | 1.972 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.066258e-02 | 1.972 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.066258e-02 | 1.972 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.066258e-02 | 1.972 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.066258e-02 | 1.972 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.066258e-02 | 1.972 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.066258e-02 | 1.972 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.010810e-02 | 1.995 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.087945e-02 | 1.963 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.200370e-02 | 1.921 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.146797e-02 | 1.941 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.158331e-02 | 1.936 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.249829e-02 | 1.903 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.261691e-02 | 1.899 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 1.261691e-02 | 1.899 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.292430e-02 | 1.889 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.294929e-02 | 1.888 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.430673e-02 | 1.844 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.432061e-02 | 1.844 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.432061e-02 | 1.844 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.634878e-02 | 1.787 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.634878e-02 | 1.787 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.689568e-02 | 1.772 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.129068e-02 | 1.672 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.222098e-02 | 1.653 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.083736e-02 | 1.681 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.086944e-02 | 1.680 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.281453e-02 | 1.642 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.449477e-02 | 1.611 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 2.455677e-02 | 1.610 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 2.635407e-02 | 1.579 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 2.635407e-02 | 1.579 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.971277e-02 | 1.527 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.992075e-02 | 1.524 | 0 | 0 |
| IRS activation | R-HSA-74713 | 3.028603e-02 | 1.519 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 3.028603e-02 | 1.519 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 3.028603e-02 | 1.519 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.093505e-02 | 1.510 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.093505e-02 | 1.510 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.289923e-02 | 1.483 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.858333e-02 | 1.414 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 3.858333e-02 | 1.414 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.858333e-02 | 1.414 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.858333e-02 | 1.414 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 3.665820e-02 | 1.436 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 3.665820e-02 | 1.436 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 3.858333e-02 | 1.414 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 3.858333e-02 | 1.414 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.424412e-02 | 1.465 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.858333e-02 | 1.414 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.908855e-02 | 1.408 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 4.293736e-02 | 1.367 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.318104e-02 | 1.365 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.318104e-02 | 1.365 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.421249e-02 | 1.354 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 4.607369e-02 | 1.337 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.757021e-02 | 1.323 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.763372e-02 | 1.322 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.226056e-02 | 1.282 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 5.226056e-02 | 1.282 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 5.409263e-02 | 1.267 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 5.409263e-02 | 1.267 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 5.736880e-02 | 1.241 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 5.869774e-02 | 1.231 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 5.869774e-02 | 1.231 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.530898e-02 | 1.185 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.013895e-02 | 1.221 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 6.530898e-02 | 1.185 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.418021e-02 | 1.193 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 6.013895e-02 | 1.221 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.530898e-02 | 1.185 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 6.594235e-02 | 1.181 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 6.013895e-02 | 1.221 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 6.353095e-02 | 1.197 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.648676e-02 | 1.177 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 5.736880e-02 | 1.241 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.736880e-02 | 1.241 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 6.713946e-02 | 1.173 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 6.713946e-02 | 1.173 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 6.757932e-02 | 1.170 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 6.772424e-02 | 1.169 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 6.772424e-02 | 1.169 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 6.795354e-02 | 1.168 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 6.836402e-02 | 1.165 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 6.861668e-02 | 1.164 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 7.021332e-02 | 1.154 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 7.400353e-02 | 1.131 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 7.400353e-02 | 1.131 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 7.400353e-02 | 1.131 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 7.400353e-02 | 1.131 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 7.400353e-02 | 1.131 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.530107e-02 | 1.123 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 7.573642e-02 | 1.121 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.863957e-02 | 1.104 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.863957e-02 | 1.104 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 7.863957e-02 | 1.104 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 9.005798e-02 | 1.045 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 9.005798e-02 | 1.045 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 8.004991e-02 | 1.097 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 8.004991e-02 | 1.097 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.004991e-02 | 1.097 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 8.724542e-02 | 1.059 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.724542e-02 | 1.059 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 9.529045e-02 | 1.021 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.534304e-02 | 1.069 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.534304e-02 | 1.069 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.534304e-02 | 1.069 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 9.529045e-02 | 1.021 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 9.118141e-02 | 1.040 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 9.470293e-02 | 1.024 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 8.869987e-02 | 1.052 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 8.917024e-02 | 1.050 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.149290e-02 | 1.039 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 8.724542e-02 | 1.059 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 9.005798e-02 | 1.045 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 8.724542e-02 | 1.059 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.699601e-02 | 1.061 | 1 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.863957e-02 | 1.104 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.863957e-02 | 1.104 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 8.724542e-02 | 1.059 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.724542e-02 | 1.059 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.538596e-02 | 1.021 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.949706e-02 | 1.002 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.019262e-01 | 0.992 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.019262e-01 | 0.992 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.019262e-01 | 0.992 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.031635e-01 | 0.986 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.038003e-01 | 0.984 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.038003e-01 | 0.984 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.074519e-01 | 0.969 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.082297e-01 | 0.966 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 1.089287e-01 | 0.963 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 1.089287e-01 | 0.963 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 1.089287e-01 | 0.963 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 1.089287e-01 | 0.963 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 1.089287e-01 | 0.963 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 1.089287e-01 | 0.963 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 1.089287e-01 | 0.963 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.089287e-01 | 0.963 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.095026e-01 | 0.961 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.141941e-01 | 0.942 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.141941e-01 | 0.942 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.141941e-01 | 0.942 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.141941e-01 | 0.942 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 1.141941e-01 | 0.942 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.141941e-01 | 0.942 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.141941e-01 | 0.942 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.157806e-01 | 0.936 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 1.748830e-01 | 0.757 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.748830e-01 | 0.757 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 1.748830e-01 | 0.757 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 2.060091e-01 | 0.686 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.060091e-01 | 0.686 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 2.060091e-01 | 0.686 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 2.060091e-01 | 0.686 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 2.060091e-01 | 0.686 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.060091e-01 | 0.686 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 2.060091e-01 | 0.686 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 2.359628e-01 | 0.627 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.359628e-01 | 0.627 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 2.359628e-01 | 0.627 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 2.647883e-01 | 0.577 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.647883e-01 | 0.577 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 2.647883e-01 | 0.577 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.925279e-01 | 0.534 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.663683e-01 | 0.779 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.663683e-01 | 0.779 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.799881e-01 | 0.745 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.192226e-01 | 0.496 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.192226e-01 | 0.496 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 3.192226e-01 | 0.496 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.269313e-01 | 0.896 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.076755e-01 | 0.683 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.449115e-01 | 0.462 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.449115e-01 | 0.462 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 3.449115e-01 | 0.462 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.532995e-01 | 0.814 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.717500e-01 | 0.765 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 2.498867e-01 | 0.602 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.907901e-01 | 0.719 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.907901e-01 | 0.719 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 2.640353e-01 | 0.578 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.934223e-01 | 0.405 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.005031e-01 | 0.698 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.005031e-01 | 0.698 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 2.781851e-01 | 0.556 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.923162e-01 | 0.534 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.923162e-01 | 0.534 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.923162e-01 | 0.534 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.163155e-01 | 0.381 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.163155e-01 | 0.381 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.064096e-01 | 0.514 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.589067e-01 | 0.799 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 3.204483e-01 | 0.494 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.204483e-01 | 0.494 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.608018e-01 | 0.584 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.710929e-01 | 0.567 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.595464e-01 | 0.338 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 4.595464e-01 | 0.338 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.595464e-01 | 0.338 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.595464e-01 | 0.338 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 3.620830e-01 | 0.441 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.620830e-01 | 0.441 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.620830e-01 | 0.441 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.757560e-01 | 0.425 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.757560e-01 | 0.425 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 4.027250e-01 | 0.395 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 2.447699e-01 | 0.611 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 4.160015e-01 | 0.381 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 4.160015e-01 | 0.381 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.646336e-01 | 0.438 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.420966e-01 | 0.354 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 3.481371e-01 | 0.458 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.782748e-01 | 0.422 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.159889e-01 | 0.381 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.549051e-01 | 0.342 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 4.675344e-01 | 0.330 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 4.027250e-01 | 0.395 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.610693e-01 | 0.442 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.812020e-01 | 0.742 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.663683e-01 | 0.779 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 2.640353e-01 | 0.578 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.717500e-01 | 0.765 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.062352e-01 | 0.514 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.757560e-01 | 0.425 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.847202e-01 | 0.733 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 3.696326e-01 | 0.432 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.962612e-01 | 0.707 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 3.449115e-01 | 0.462 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 2.103299e-01 | 0.677 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.498867e-01 | 0.602 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.934223e-01 | 0.405 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.163155e-01 | 0.381 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.350993e-01 | 0.869 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 2.261546e-01 | 0.646 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.060091e-01 | 0.686 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.268148e-01 | 0.897 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.192226e-01 | 0.496 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.443241e-01 | 0.841 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 4.595464e-01 | 0.338 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 4.595464e-01 | 0.338 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 3.767743e-01 | 0.424 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.493813e-01 | 0.826 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 4.291279e-01 | 0.367 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.220939e-01 | 0.913 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.718633e-01 | 0.765 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 2.200549e-01 | 0.657 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.060091e-01 | 0.686 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 1.799881e-01 | 0.745 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 1.799881e-01 | 0.745 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 4.595464e-01 | 0.338 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.099834e-01 | 0.678 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.469014e-01 | 0.833 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.204483e-01 | 0.494 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 4.466935e-01 | 0.350 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.482990e-01 | 0.458 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.359628e-01 | 0.627 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 1.663683e-01 | 0.779 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 3.696326e-01 | 0.432 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.185372e-01 | 0.926 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 1.717500e-01 | 0.765 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.528546e-01 | 0.816 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.814273e-01 | 0.551 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 4.027250e-01 | 0.395 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.419080e-01 | 0.616 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.781851e-01 | 0.556 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.532995e-01 | 0.814 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.060091e-01 | 0.686 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 2.359628e-01 | 0.627 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 2.647883e-01 | 0.577 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 2.647883e-01 | 0.577 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.397444e-01 | 0.855 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 2.925279e-01 | 0.534 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.663683e-01 | 0.779 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 3.192226e-01 | 0.496 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.355309e-01 | 0.868 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 3.449115e-01 | 0.462 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.696326e-01 | 0.432 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 3.934223e-01 | 0.405 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.934223e-01 | 0.405 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 3.934223e-01 | 0.405 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 2.005031e-01 | 0.698 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.163155e-01 | 0.381 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 4.383460e-01 | 0.358 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 4.595464e-01 | 0.338 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.595464e-01 | 0.338 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 3.620830e-01 | 0.441 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.757560e-01 | 0.425 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 3.893067e-01 | 0.410 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.160015e-01 | 0.381 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.707242e-01 | 0.431 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.287930e-01 | 0.890 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.442386e-01 | 0.612 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.957959e-01 | 0.529 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 2.005031e-01 | 0.698 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 2.831305e-01 | 0.548 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.359628e-01 | 0.627 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.216824e-01 | 0.654 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.710929e-01 | 0.567 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.710929e-01 | 0.567 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 2.837323e-01 | 0.547 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.772159e-01 | 0.557 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.490283e-01 | 0.457 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.717500e-01 | 0.765 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.265147e-01 | 0.486 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.917958e-01 | 0.535 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 2.670854e-01 | 0.573 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.529417e-01 | 0.815 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.192226e-01 | 0.496 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.355309e-01 | 0.868 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.696326e-01 | 0.432 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.934223e-01 | 0.405 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.711316e-01 | 0.767 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 4.595464e-01 | 0.338 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.668521e-01 | 0.574 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.989021e-01 | 0.701 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 4.549008e-01 | 0.342 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.518823e-01 | 0.818 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 4.530513e-01 | 0.344 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.312553e-01 | 0.882 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 2.103299e-01 | 0.677 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.538969e-01 | 0.595 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 3.376449e-01 | 0.472 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 1.443241e-01 | 0.841 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.410501e-01 | 0.851 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.939008e-01 | 0.712 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 3.344163e-01 | 0.476 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.538969e-01 | 0.595 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.713335e-01 | 0.566 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.845837e-01 | 0.734 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.713335e-01 | 0.566 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.249559e-01 | 0.903 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 4.595464e-01 | 0.338 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.032959e-01 | 0.518 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.021897e-01 | 0.520 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 3.368938e-01 | 0.473 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 1.425387e-01 | 0.846 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.748830e-01 | 0.757 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 2.060091e-01 | 0.686 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 2.647883e-01 | 0.577 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 3.192226e-01 | 0.496 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 3.449115e-01 | 0.462 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 3.449115e-01 | 0.462 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.696326e-01 | 0.432 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.696326e-01 | 0.432 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 3.934223e-01 | 0.405 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.608018e-01 | 0.584 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.608018e-01 | 0.584 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 3.757560e-01 | 0.425 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.202599e-01 | 0.657 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 2.638115e-01 | 0.579 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 3.749848e-01 | 0.426 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 2.485188e-01 | 0.605 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.637611e-01 | 0.786 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.309657e-01 | 0.480 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 1.748830e-01 | 0.757 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.925279e-01 | 0.534 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.696326e-01 | 0.432 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.907901e-01 | 0.719 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.403867e-01 | 0.619 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 4.675344e-01 | 0.330 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.549766e-01 | 0.342 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.675344e-01 | 0.330 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.676731e-01 | 0.776 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 2.710929e-01 | 0.567 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.060091e-01 | 0.686 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 2.359628e-01 | 0.627 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.359628e-01 | 0.627 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 2.647883e-01 | 0.577 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 2.647883e-01 | 0.577 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.529417e-01 | 0.815 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 1.799881e-01 | 0.745 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.192226e-01 | 0.496 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 3.192226e-01 | 0.496 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.192226e-01 | 0.496 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.192226e-01 | 0.496 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 3.696326e-01 | 0.432 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.595464e-01 | 0.338 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 4.595464e-01 | 0.338 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.620830e-01 | 0.441 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.752706e-01 | 0.560 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.211823e-01 | 0.493 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.930301e-01 | 0.714 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.173736e-01 | 0.379 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.420966e-01 | 0.354 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.907901e-01 | 0.719 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 1.469014e-01 | 0.833 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.481672e-01 | 0.605 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.362698e-01 | 0.866 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.216824e-01 | 0.654 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.696326e-01 | 0.432 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.163155e-01 | 0.381 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.021897e-01 | 0.520 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.641130e-01 | 0.578 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.469014e-01 | 0.833 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.522987e-01 | 0.598 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 3.438548e-01 | 0.464 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 3.438548e-01 | 0.464 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.482990e-01 | 0.458 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.334409e-01 | 0.477 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 2.505632e-01 | 0.601 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.017122e-01 | 0.396 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 2.647883e-01 | 0.577 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 2.647883e-01 | 0.577 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 2.925279e-01 | 0.534 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 1.937676e-01 | 0.713 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.696326e-01 | 0.432 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 2.923162e-01 | 0.534 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.163155e-01 | 0.381 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 4.163155e-01 | 0.381 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 2.917958e-01 | 0.535 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.420966e-01 | 0.354 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.763006e-01 | 0.559 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.663683e-01 | 0.779 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.216824e-01 | 0.654 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.498867e-01 | 0.602 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.640353e-01 | 0.578 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.204483e-01 | 0.494 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.204483e-01 | 0.494 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.643534e-01 | 0.784 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 4.068225e-01 | 0.391 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 1.443241e-01 | 0.841 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.381352e-01 | 0.623 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 4.560871e-01 | 0.341 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.702427e-01 | 0.568 | 1 | 1 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 3.893067e-01 | 0.410 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.027250e-01 | 0.395 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 4.483241e-01 | 0.348 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.083464e-01 | 0.389 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.361610e-01 | 0.627 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.530108e-01 | 0.452 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.531773e-01 | 0.815 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 2.447699e-01 | 0.611 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.083464e-01 | 0.389 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.083464e-01 | 0.389 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 3.934223e-01 | 0.405 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 2.337146e-01 | 0.631 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 4.595464e-01 | 0.338 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 4.595464e-01 | 0.338 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.620830e-01 | 0.441 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 3.021897e-01 | 0.520 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.745507e-01 | 0.426 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 4.045328e-01 | 0.393 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.522987e-01 | 0.598 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.245717e-01 | 0.649 | 1 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.497734e-01 | 0.602 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.307886e-01 | 0.366 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 4.461648e-01 | 0.351 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 3.126006e-01 | 0.505 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.322687e-01 | 0.479 | 1 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 2.359628e-01 | 0.627 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.696326e-01 | 0.432 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 3.934223e-01 | 0.405 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.163155e-01 | 0.381 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 3.482990e-01 | 0.458 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.523911e-01 | 0.453 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 3.334409e-01 | 0.477 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.216824e-01 | 0.654 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 2.640353e-01 | 0.578 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.064096e-01 | 0.514 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 3.126006e-01 | 0.505 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 2.781851e-01 | 0.556 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.461648e-01 | 0.351 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 2.443424e-01 | 0.612 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 3.482990e-01 | 0.458 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 3.542547e-01 | 0.451 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.832172e-01 | 0.548 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.620830e-01 | 0.441 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 4.549008e-01 | 0.342 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.064096e-01 | 0.514 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.934223e-01 | 0.405 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.620830e-01 | 0.441 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.685386e-01 | 0.773 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.564831e-01 | 0.448 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.481606e-01 | 0.605 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.560871e-01 | 0.341 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.574208e-01 | 0.589 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.781851e-01 | 0.556 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.482990e-01 | 0.458 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 3.632408e-01 | 0.440 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.302822e-01 | 0.638 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.595464e-01 | 0.338 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.211329e-01 | 0.376 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.406227e-01 | 0.468 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.625238e-01 | 0.789 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.964799e-01 | 0.528 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.608018e-01 | 0.584 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.962432e-01 | 0.707 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.064096e-01 | 0.514 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.093266e-01 | 0.510 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.869507e-01 | 0.412 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 2.608018e-01 | 0.584 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.040547e-01 | 0.394 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.757011e-01 | 0.323 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 4.757011e-01 | 0.323 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 4.757011e-01 | 0.323 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 4.793959e-01 | 0.319 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 4.799477e-01 | 0.319 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 4.799477e-01 | 0.319 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 4.799477e-01 | 0.319 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 4.799477e-01 | 0.319 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 4.799477e-01 | 0.319 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 4.799477e-01 | 0.319 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.799477e-01 | 0.319 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 4.799477e-01 | 0.319 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.799884e-01 | 0.319 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 4.799922e-01 | 0.319 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.799922e-01 | 0.319 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.799922e-01 | 0.319 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.799922e-01 | 0.319 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.799922e-01 | 0.319 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 4.830136e-01 | 0.316 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 4.853851e-01 | 0.314 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 4.895943e-01 | 0.310 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 4.895943e-01 | 0.310 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 4.895943e-01 | 0.310 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 4.895943e-01 | 0.310 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 4.922694e-01 | 0.308 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 4.922694e-01 | 0.308 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 4.922694e-01 | 0.308 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 4.922694e-01 | 0.308 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 4.922694e-01 | 0.308 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 4.949823e-01 | 0.305 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 4.968004e-01 | 0.304 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 4.972207e-01 | 0.303 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 4.972207e-01 | 0.303 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 4.995801e-01 | 0.301 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 4.995801e-01 | 0.301 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 4.995801e-01 | 0.301 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 4.995801e-01 | 0.301 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 4.995801e-01 | 0.301 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 4.995801e-01 | 0.301 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 4.995801e-01 | 0.301 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 4.995801e-01 | 0.301 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.042402e-01 | 0.297 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 5.043618e-01 | 0.297 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 5.043618e-01 | 0.297 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.044894e-01 | 0.297 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 5.122743e-01 | 0.290 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 5.122743e-01 | 0.290 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 5.162660e-01 | 0.287 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 5.162660e-01 | 0.287 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 5.181808e-01 | 0.286 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 5.181808e-01 | 0.286 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.184725e-01 | 0.285 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 5.184725e-01 | 0.285 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.184725e-01 | 0.285 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.184725e-01 | 0.285 | 0 | 0 |
| Synthesis of 12-eicosatetraenoic acid derivatives | R-HSA-2142712 | 5.184725e-01 | 0.285 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 5.184725e-01 | 0.285 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.184725e-01 | 0.285 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.184725e-01 | 0.285 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 5.202484e-01 | 0.284 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.232212e-01 | 0.281 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.252226e-01 | 0.280 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 5.279789e-01 | 0.277 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.279789e-01 | 0.277 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 5.279789e-01 | 0.277 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 5.360086e-01 | 0.271 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.366528e-01 | 0.270 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.366528e-01 | 0.270 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 5.366528e-01 | 0.270 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.366528e-01 | 0.270 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 5.366528e-01 | 0.270 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 5.366528e-01 | 0.270 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.366528e-01 | 0.270 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.366528e-01 | 0.270 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 5.366528e-01 | 0.270 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.366528e-01 | 0.270 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 5.394981e-01 | 0.268 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 5.394981e-01 | 0.268 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 5.394981e-01 | 0.268 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 5.394981e-01 | 0.268 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 5.394981e-01 | 0.268 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 5.394981e-01 | 0.268 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.460715e-01 | 0.263 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 5.483340e-01 | 0.261 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 5.508213e-01 | 0.259 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.508213e-01 | 0.259 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 5.508213e-01 | 0.259 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 5.508213e-01 | 0.259 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 5.508213e-01 | 0.259 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 5.515053e-01 | 0.258 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.541478e-01 | 0.256 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.541478e-01 | 0.256 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.541478e-01 | 0.256 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.541478e-01 | 0.256 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.541478e-01 | 0.256 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.541478e-01 | 0.256 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 5.541478e-01 | 0.256 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.545616e-01 | 0.256 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.545616e-01 | 0.256 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 5.580742e-01 | 0.253 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 5.591506e-01 | 0.252 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 5.597261e-01 | 0.252 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 5.597261e-01 | 0.252 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 5.619471e-01 | 0.250 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 5.648838e-01 | 0.248 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.709832e-01 | 0.243 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.709832e-01 | 0.243 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 5.709832e-01 | 0.243 | 0 | 0 |
| Synthesis of 15-eicosatetraenoic acid derivatives | R-HSA-2142770 | 5.709832e-01 | 0.243 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 5.709832e-01 | 0.243 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 5.728741e-01 | 0.242 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 5.728741e-01 | 0.242 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 5.728741e-01 | 0.242 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 5.742271e-01 | 0.241 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 5.769776e-01 | 0.239 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 5.790655e-01 | 0.237 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 5.816555e-01 | 0.235 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 5.816555e-01 | 0.235 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 5.836016e-01 | 0.234 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.836016e-01 | 0.234 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 5.844704e-01 | 0.233 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.855600e-01 | 0.232 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.855600e-01 | 0.232 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 5.864025e-01 | 0.232 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 5.871839e-01 | 0.231 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 5.871839e-01 | 0.231 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 5.871839e-01 | 0.231 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.871839e-01 | 0.231 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 5.871839e-01 | 0.231 | 0 | 0 |
| PKA activation | R-HSA-163615 | 5.871839e-01 | 0.231 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 5.871839e-01 | 0.231 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 5.871839e-01 | 0.231 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 5.871839e-01 | 0.231 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 5.890090e-01 | 0.230 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 5.890090e-01 | 0.230 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 5.894271e-01 | 0.230 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.940305e-01 | 0.226 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 5.941290e-01 | 0.226 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 6.010448e-01 | 0.221 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 6.027737e-01 | 0.220 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.027737e-01 | 0.220 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.027737e-01 | 0.220 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 6.027737e-01 | 0.220 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.027737e-01 | 0.220 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.027737e-01 | 0.220 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.027737e-01 | 0.220 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.027737e-01 | 0.220 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 6.027737e-01 | 0.220 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 6.027737e-01 | 0.220 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.027737e-01 | 0.220 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.027737e-01 | 0.220 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 6.027737e-01 | 0.220 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 6.044561e-01 | 0.219 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 6.044561e-01 | 0.219 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 6.044561e-01 | 0.219 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 6.050390e-01 | 0.218 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 6.106082e-01 | 0.214 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 6.106312e-01 | 0.214 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.106312e-01 | 0.214 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 6.145016e-01 | 0.211 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.145831e-01 | 0.211 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 6.145831e-01 | 0.211 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 6.145831e-01 | 0.211 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 6.145831e-01 | 0.211 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 6.145831e-01 | 0.211 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 6.172638e-01 | 0.210 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.177758e-01 | 0.209 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.177758e-01 | 0.209 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.177758e-01 | 0.209 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.177758e-01 | 0.209 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.177758e-01 | 0.209 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.177758e-01 | 0.209 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 6.177758e-01 | 0.209 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 6.177758e-01 | 0.209 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 6.177758e-01 | 0.209 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.177758e-01 | 0.209 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 6.177758e-01 | 0.209 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 6.201209e-01 | 0.208 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.246134e-01 | 0.204 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 6.322121e-01 | 0.199 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 6.322121e-01 | 0.199 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 6.322121e-01 | 0.199 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 6.322121e-01 | 0.199 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.322121e-01 | 0.199 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.322121e-01 | 0.199 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 6.322121e-01 | 0.199 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 6.322121e-01 | 0.199 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 6.322121e-01 | 0.199 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.342383e-01 | 0.198 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 6.342383e-01 | 0.198 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 6.382955e-01 | 0.195 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 6.424463e-01 | 0.192 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 6.437680e-01 | 0.191 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.450137e-01 | 0.190 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.461040e-01 | 0.190 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.461040e-01 | 0.190 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 6.461040e-01 | 0.190 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 6.461040e-01 | 0.190 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 6.516492e-01 | 0.186 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 6.522924e-01 | 0.186 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 6.531006e-01 | 0.185 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 6.536505e-01 | 0.185 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.582017e-01 | 0.182 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 6.594720e-01 | 0.181 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 6.594720e-01 | 0.181 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 6.594720e-01 | 0.181 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.594720e-01 | 0.181 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 6.594720e-01 | 0.181 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.622374e-01 | 0.179 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 6.643764e-01 | 0.178 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 6.643764e-01 | 0.178 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 6.650778e-01 | 0.177 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 6.662002e-01 | 0.176 | 0 | 0 |
| Disease | R-HSA-1643685 | 6.677486e-01 | 0.175 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 6.696605e-01 | 0.174 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.710556e-01 | 0.173 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 6.710556e-01 | 0.173 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.711797e-01 | 0.173 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 6.711797e-01 | 0.173 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 6.711797e-01 | 0.173 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 6.711797e-01 | 0.173 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.711797e-01 | 0.173 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.711797e-01 | 0.173 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.723359e-01 | 0.172 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.723359e-01 | 0.172 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 6.723359e-01 | 0.172 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.723861e-01 | 0.172 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 6.773565e-01 | 0.169 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 6.799293e-01 | 0.168 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 6.799293e-01 | 0.168 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 6.799293e-01 | 0.168 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 6.799293e-01 | 0.168 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 6.799293e-01 | 0.168 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 6.847145e-01 | 0.164 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.847145e-01 | 0.164 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 6.847145e-01 | 0.164 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 6.884879e-01 | 0.162 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 6.897050e-01 | 0.161 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 6.897050e-01 | 0.161 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 6.936050e-01 | 0.159 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.936050e-01 | 0.159 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 6.966263e-01 | 0.157 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 6.966263e-01 | 0.157 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 6.966263e-01 | 0.157 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 6.966263e-01 | 0.157 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 6.966263e-01 | 0.157 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 6.966263e-01 | 0.157 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 6.966263e-01 | 0.157 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 6.966263e-01 | 0.157 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 6.966263e-01 | 0.157 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 6.966263e-01 | 0.157 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.968575e-01 | 0.157 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 6.968575e-01 | 0.157 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.968575e-01 | 0.157 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 6.999944e-01 | 0.155 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 6.999944e-01 | 0.155 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.004434e-01 | 0.155 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.050401e-01 | 0.152 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 7.050401e-01 | 0.152 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 7.080887e-01 | 0.150 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.080887e-01 | 0.150 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.080887e-01 | 0.150 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.080887e-01 | 0.150 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.080887e-01 | 0.150 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.080887e-01 | 0.150 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.191187e-01 | 0.143 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 7.191187e-01 | 0.143 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 7.191187e-01 | 0.143 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.191187e-01 | 0.143 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.191187e-01 | 0.143 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.191187e-01 | 0.143 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 7.284884e-01 | 0.138 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 7.284884e-01 | 0.138 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 7.284884e-01 | 0.138 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.284884e-01 | 0.138 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 7.297325e-01 | 0.137 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 7.297325e-01 | 0.137 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 7.297325e-01 | 0.137 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.297325e-01 | 0.137 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 7.359458e-01 | 0.133 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 7.359458e-01 | 0.133 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 7.359458e-01 | 0.133 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 7.359458e-01 | 0.133 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 7.359458e-01 | 0.133 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 7.359458e-01 | 0.133 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 7.390450e-01 | 0.131 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.399459e-01 | 0.131 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.399459e-01 | 0.131 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.399459e-01 | 0.131 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.399459e-01 | 0.131 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.399459e-01 | 0.131 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.399459e-01 | 0.131 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.432281e-01 | 0.129 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 7.432281e-01 | 0.129 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 7.432281e-01 | 0.129 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 7.432281e-01 | 0.129 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 7.468546e-01 | 0.127 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 7.468546e-01 | 0.127 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 7.497740e-01 | 0.125 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.497740e-01 | 0.125 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 7.497740e-01 | 0.125 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 7.497740e-01 | 0.125 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.497740e-01 | 0.125 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.503378e-01 | 0.125 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.503378e-01 | 0.125 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.503378e-01 | 0.125 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.510030e-01 | 0.124 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 7.581967e-01 | 0.120 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 7.592312e-01 | 0.120 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.592312e-01 | 0.120 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.592312e-01 | 0.120 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 7.625178e-01 | 0.118 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 7.651628e-01 | 0.116 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 7.683315e-01 | 0.114 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 7.683315e-01 | 0.114 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 7.730491e-01 | 0.112 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 7.770884e-01 | 0.110 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.770884e-01 | 0.110 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 7.770884e-01 | 0.110 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 7.770884e-01 | 0.110 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 7.770884e-01 | 0.110 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.770884e-01 | 0.110 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 7.770884e-01 | 0.110 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 7.770884e-01 | 0.110 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 7.773953e-01 | 0.109 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 7.833909e-01 | 0.106 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 7.842500e-01 | 0.106 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.855148e-01 | 0.105 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.855148e-01 | 0.105 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 7.855148e-01 | 0.105 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 7.855148e-01 | 0.105 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.855148e-01 | 0.105 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 7.894193e-01 | 0.103 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 7.895217e-01 | 0.103 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 7.895217e-01 | 0.103 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 7.903237e-01 | 0.102 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 7.936232e-01 | 0.100 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 7.936232e-01 | 0.100 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 7.936232e-01 | 0.100 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.936232e-01 | 0.100 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 7.936232e-01 | 0.100 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 7.936232e-01 | 0.100 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.936232e-01 | 0.100 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 7.936232e-01 | 0.100 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 7.948079e-01 | 0.100 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 7.992147e-01 | 0.097 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 8.013260e-01 | 0.096 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 8.013260e-01 | 0.096 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 8.014255e-01 | 0.096 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.014255e-01 | 0.096 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.021385e-01 | 0.096 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.060438e-01 | 0.094 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 8.070051e-01 | 0.093 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.089333e-01 | 0.092 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.089333e-01 | 0.092 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.089333e-01 | 0.092 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.089333e-01 | 0.092 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 8.089333e-01 | 0.092 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.089333e-01 | 0.092 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.089333e-01 | 0.092 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.089333e-01 | 0.092 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.089333e-01 | 0.092 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 8.090765e-01 | 0.092 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 8.125394e-01 | 0.090 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 8.125394e-01 | 0.090 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.125394e-01 | 0.090 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 8.125394e-01 | 0.090 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 8.136709e-01 | 0.090 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 8.161577e-01 | 0.088 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.161577e-01 | 0.088 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.161577e-01 | 0.088 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.161577e-01 | 0.088 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.161577e-01 | 0.088 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 8.161577e-01 | 0.088 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 8.179315e-01 | 0.087 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.179315e-01 | 0.087 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.182689e-01 | 0.087 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.183110e-01 | 0.087 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.201755e-01 | 0.086 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.231093e-01 | 0.085 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.231093e-01 | 0.085 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.231093e-01 | 0.085 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 8.231093e-01 | 0.085 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.231093e-01 | 0.085 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 8.231844e-01 | 0.085 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 8.231844e-01 | 0.085 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.283009e-01 | 0.082 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.283009e-01 | 0.082 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.297985e-01 | 0.081 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 8.297985e-01 | 0.081 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.314494e-01 | 0.080 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.314494e-01 | 0.080 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 8.332837e-01 | 0.079 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 8.332837e-01 | 0.079 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 8.333586e-01 | 0.079 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.362351e-01 | 0.078 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.362351e-01 | 0.078 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 8.362351e-01 | 0.078 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.362351e-01 | 0.078 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 8.372081e-01 | 0.077 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.381357e-01 | 0.077 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.424287e-01 | 0.074 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.424287e-01 | 0.074 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 8.428596e-01 | 0.074 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 8.428596e-01 | 0.074 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.483885e-01 | 0.071 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.483885e-01 | 0.071 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.483885e-01 | 0.071 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.483885e-01 | 0.071 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.483885e-01 | 0.071 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.511031e-01 | 0.070 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 8.519341e-01 | 0.070 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 8.519341e-01 | 0.070 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 8.541231e-01 | 0.068 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.541231e-01 | 0.068 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 8.563100e-01 | 0.067 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 8.589659e-01 | 0.066 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.596412e-01 | 0.066 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 8.596412e-01 | 0.066 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 8.596412e-01 | 0.066 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 8.605362e-01 | 0.065 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 8.605362e-01 | 0.065 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 8.625581e-01 | 0.064 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.636216e-01 | 0.064 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.649509e-01 | 0.063 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 8.649509e-01 | 0.063 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 8.649509e-01 | 0.063 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 8.649509e-01 | 0.063 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.649509e-01 | 0.063 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 8.686649e-01 | 0.061 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 8.699121e-01 | 0.061 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.700600e-01 | 0.060 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 8.700600e-01 | 0.060 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 8.700600e-01 | 0.060 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 8.700600e-01 | 0.060 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.700600e-01 | 0.060 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.700600e-01 | 0.060 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 8.704251e-01 | 0.060 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 8.728568e-01 | 0.059 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 8.728568e-01 | 0.059 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.749761e-01 | 0.058 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.749761e-01 | 0.058 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 8.752330e-01 | 0.058 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 8.763631e-01 | 0.057 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 8.793380e-01 | 0.056 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.797066e-01 | 0.056 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 8.797066e-01 | 0.056 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.797066e-01 | 0.056 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 8.797066e-01 | 0.056 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.800542e-01 | 0.055 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.809794e-01 | 0.055 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 8.824673e-01 | 0.054 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 8.842583e-01 | 0.053 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.842583e-01 | 0.053 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 8.854716e-01 | 0.053 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 8.864948e-01 | 0.052 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 8.886380e-01 | 0.051 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 8.886380e-01 | 0.051 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 8.886380e-01 | 0.051 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 8.893532e-01 | 0.051 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 8.914258e-01 | 0.050 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 8.914258e-01 | 0.050 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 8.918980e-01 | 0.050 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.928155e-01 | 0.049 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.928523e-01 | 0.049 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.928523e-01 | 0.049 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.928523e-01 | 0.049 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.938232e-01 | 0.049 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 8.943499e-01 | 0.048 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 8.969074e-01 | 0.047 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.969074e-01 | 0.047 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.969074e-01 | 0.047 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 8.970536e-01 | 0.047 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 8.997681e-01 | 0.046 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.008092e-01 | 0.045 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.008092e-01 | 0.045 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.008092e-01 | 0.045 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.031702e-01 | 0.044 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.045636e-01 | 0.044 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.050043e-01 | 0.043 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.050043e-01 | 0.043 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.050043e-01 | 0.043 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 9.050043e-01 | 0.043 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.061113e-01 | 0.043 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 9.081761e-01 | 0.042 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.098771e-01 | 0.041 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 9.110194e-01 | 0.040 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 9.116521e-01 | 0.040 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.116521e-01 | 0.040 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.128870e-01 | 0.040 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 9.149966e-01 | 0.039 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 9.149966e-01 | 0.039 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 9.149966e-01 | 0.039 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.170603e-01 | 0.038 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.182148e-01 | 0.037 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.182148e-01 | 0.037 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.192118e-01 | 0.037 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.192617e-01 | 0.037 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.196039e-01 | 0.036 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 9.213113e-01 | 0.036 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 9.235624e-01 | 0.035 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.235624e-01 | 0.035 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.242908e-01 | 0.034 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.250165e-01 | 0.034 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.271576e-01 | 0.033 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.284738e-01 | 0.032 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.299161e-01 | 0.032 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.299161e-01 | 0.032 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 9.299161e-01 | 0.032 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 9.312574e-01 | 0.031 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.321723e-01 | 0.031 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.325702e-01 | 0.030 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 9.325702e-01 | 0.030 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 9.325702e-01 | 0.030 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.338621e-01 | 0.030 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.342336e-01 | 0.030 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.351240e-01 | 0.029 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.375812e-01 | 0.028 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.399455e-01 | 0.027 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.402467e-01 | 0.027 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.422204e-01 | 0.026 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.431354e-01 | 0.025 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 9.444092e-01 | 0.025 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.444092e-01 | 0.025 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.444092e-01 | 0.025 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.465153e-01 | 0.024 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.466414e-01 | 0.024 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.483163e-01 | 0.023 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.504914e-01 | 0.022 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.515170e-01 | 0.022 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 9.515170e-01 | 0.022 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 9.523674e-01 | 0.021 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.523674e-01 | 0.021 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.523674e-01 | 0.021 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 9.523674e-01 | 0.021 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.523674e-01 | 0.021 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.541723e-01 | 0.020 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 9.541723e-01 | 0.020 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.559091e-01 | 0.020 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 9.559929e-01 | 0.020 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.575800e-01 | 0.019 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.591878e-01 | 0.018 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.599644e-01 | 0.018 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 9.607347e-01 | 0.017 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 9.611001e-01 | 0.017 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.612931e-01 | 0.017 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 9.636552e-01 | 0.016 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.636552e-01 | 0.016 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.650330e-01 | 0.015 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.663388e-01 | 0.015 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.671564e-01 | 0.015 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.676342e-01 | 0.014 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.681414e-01 | 0.014 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.700422e-01 | 0.013 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 9.711782e-01 | 0.013 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.753083e-01 | 0.011 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.754035e-01 | 0.011 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.762449e-01 | 0.010 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.770427e-01 | 0.010 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.780131e-01 | 0.010 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 9.787743e-01 | 0.009 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.804221e-01 | 0.009 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.811651e-01 | 0.008 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.815971e-01 | 0.008 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 9.831236e-01 | 0.007 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.838657e-01 | 0.007 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.846771e-01 | 0.007 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.850674e-01 | 0.007 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.853378e-01 | 0.006 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 9.856343e-01 | 0.006 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.856343e-01 | 0.006 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.860495e-01 | 0.006 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.861797e-01 | 0.006 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.876950e-01 | 0.005 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.886119e-01 | 0.005 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.886119e-01 | 0.005 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.888447e-01 | 0.005 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.890444e-01 | 0.005 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.893351e-01 | 0.005 | 0 | 0 |
| Translation | R-HSA-72766 | 9.901597e-01 | 0.004 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.906166e-01 | 0.004 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.909730e-01 | 0.004 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.913160e-01 | 0.004 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.918588e-01 | 0.004 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.928453e-01 | 0.003 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.936305e-01 | 0.003 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.936582e-01 | 0.003 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.941056e-01 | 0.003 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.945453e-01 | 0.002 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.961522e-01 | 0.002 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 9.964188e-01 | 0.002 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.965402e-01 | 0.002 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 9.969536e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.974890e-01 | 0.001 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.982969e-01 | 0.001 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.984843e-01 | 0.001 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.985551e-01 | 0.001 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.987078e-01 | 0.001 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.987450e-01 | 0.001 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.988120e-01 | 0.001 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.988489e-01 | 0.001 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.989782e-01 | 0.000 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.991736e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.993308e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.994777e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.995092e-01 | 0.000 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 9.995830e-01 | 0.000 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 9.996271e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.998345e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.998794e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999353e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999449e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999577e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999715e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999845e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999878e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| HSF1 activation | R-HSA-3371511 | 1.110223e-16 | 15.955 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.110223e-16 | 15.955 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.110223e-16 | 15.955 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.110223e-16 | 15.955 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.110223e-16 | 15.955 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 1 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 1 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 2.220446e-16 | 15.654 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 3.330669e-16 | 15.477 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 4.440892e-16 | 15.353 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.109424e-15 | 14.676 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.664535e-15 | 14.574 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.576517e-14 | 13.802 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.575717e-14 | 13.589 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.330669e-14 | 13.477 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.974598e-14 | 13.401 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 4.596323e-14 | 13.338 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.594725e-14 | 13.181 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.355582e-13 | 12.868 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.026157e-13 | 12.693 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.009504e-13 | 12.697 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.294831e-13 | 12.639 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.622658e-13 | 12.441 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 7.335244e-13 | 12.135 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.501110e-12 | 11.602 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.600031e-12 | 11.585 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.803757e-12 | 11.552 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.980505e-12 | 11.526 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.924661e-12 | 11.534 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.613221e-12 | 11.442 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.590017e-12 | 11.445 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.806600e-12 | 11.318 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 4.797718e-12 | 11.319 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 5.940026e-12 | 11.226 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 5.940026e-12 | 11.226 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.726330e-11 | 10.763 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.907541e-11 | 10.720 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.442224e-11 | 10.612 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.442224e-11 | 10.612 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.772305e-11 | 10.557 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.871281e-11 | 10.412 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.999234e-11 | 10.398 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 4.969314e-11 | 10.304 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 5.199519e-11 | 10.284 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 7.052514e-11 | 10.152 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 7.177436e-11 | 10.144 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 7.696499e-11 | 10.114 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.069425e-10 | 9.971 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.320274e-10 | 9.879 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.893333e-10 | 9.723 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.224936e-10 | 9.653 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.251461e-10 | 9.648 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.384486e-10 | 9.623 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 3.474331e-10 | 9.459 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.861801e-10 | 9.413 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.216485e-10 | 9.375 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.668823e-10 | 9.331 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.079286e-10 | 9.294 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 6.551811e-10 | 9.184 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 7.581671e-10 | 9.120 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.052910e-09 | 8.978 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.167727e-09 | 8.933 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.377602e-09 | 8.861 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.467466e-09 | 8.833 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.637753e-09 | 8.786 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.204392e-09 | 8.657 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.204392e-09 | 8.657 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.307605e-09 | 8.637 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.548285e-09 | 8.594 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.657389e-09 | 8.576 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.676293e-09 | 8.572 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.110837e-09 | 8.507 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.378463e-09 | 8.471 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 4.302447e-09 | 8.366 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.065880e-09 | 8.295 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 5.166682e-09 | 8.287 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 5.528273e-09 | 8.257 | 0 | 0 |
| Translation | R-HSA-72766 | 5.590755e-09 | 8.253 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.342011e-09 | 8.198 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 8.030209e-09 | 8.095 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.031794e-08 | 7.986 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.060066e-08 | 7.975 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.413188e-08 | 7.850 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.561445e-08 | 7.806 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.387851e-08 | 7.622 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.526969e-08 | 7.597 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.715422e-08 | 7.566 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 3.118654e-08 | 7.506 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.100923e-08 | 7.387 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.603825e-08 | 7.337 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.637102e-08 | 7.334 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.122285e-08 | 7.291 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 7.098739e-08 | 7.149 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 7.408627e-08 | 7.130 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 7.408627e-08 | 7.130 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 8.270982e-08 | 7.082 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 8.809929e-08 | 7.055 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 9.628279e-08 | 7.016 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.006460e-07 | 6.997 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.125265e-07 | 6.949 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.461995e-07 | 6.835 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.569430e-07 | 6.804 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.886962e-07 | 6.724 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.181618e-07 | 6.661 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.312142e-07 | 6.636 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.834732e-07 | 6.547 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 3.034669e-07 | 6.518 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.039743e-07 | 6.517 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.216428e-07 | 6.493 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 3.434304e-07 | 6.464 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 3.505168e-07 | 6.455 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 4.079376e-07 | 6.389 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 5.787086e-07 | 6.238 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 5.823209e-07 | 6.235 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 6.558247e-07 | 6.183 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 6.579129e-07 | 6.182 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 6.579129e-07 | 6.182 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 6.579129e-07 | 6.182 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 6.847281e-07 | 6.164 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 7.372188e-07 | 6.132 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 7.855157e-07 | 6.105 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 7.920096e-07 | 6.101 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.016913e-06 | 5.993 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.016913e-06 | 5.993 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.016913e-06 | 5.993 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.016913e-06 | 5.993 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.016913e-06 | 5.993 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.016913e-06 | 5.993 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.088092e-06 | 5.963 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.148643e-06 | 5.940 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.188402e-06 | 5.925 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.901169e-06 | 5.721 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.466749e-06 | 5.608 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.591210e-06 | 5.586 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.673938e-06 | 5.573 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.673938e-06 | 5.573 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.984871e-06 | 5.525 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.996354e-06 | 5.523 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.996354e-06 | 5.523 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.108771e-06 | 5.507 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 3.114991e-06 | 5.507 | 0 | 0 |
| Immune System | R-HSA-168256 | 3.237430e-06 | 5.490 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.434398e-06 | 5.464 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.482384e-06 | 5.458 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.681931e-06 | 5.434 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.115531e-06 | 5.386 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 4.707660e-06 | 5.327 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.707660e-06 | 5.327 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.015639e-06 | 5.221 | 1 | 0 |
| Platelet degranulation | R-HSA-114608 | 6.995623e-06 | 5.155 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 7.800700e-06 | 5.108 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 8.980443e-06 | 5.047 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 8.980443e-06 | 5.047 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 9.031862e-06 | 5.044 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 9.980551e-06 | 5.001 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 9.980551e-06 | 5.001 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.054565e-05 | 4.977 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.510121e-05 | 4.821 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.563529e-05 | 4.806 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.630537e-05 | 4.788 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.686794e-05 | 4.773 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.745858e-05 | 4.758 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.797175e-05 | 4.745 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.027552e-05 | 4.693 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.835617e-05 | 4.736 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.045279e-05 | 4.689 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.204599e-05 | 4.657 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.862032e-05 | 4.543 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.165613e-05 | 4.500 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 3.427278e-05 | 4.465 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.456647e-05 | 4.461 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.462351e-05 | 4.461 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.505892e-05 | 4.455 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.545943e-05 | 4.450 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.588346e-05 | 4.445 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 4.101303e-05 | 4.387 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.247015e-05 | 4.372 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.247015e-05 | 4.372 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 4.264132e-05 | 4.370 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.346041e-05 | 4.362 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 4.418102e-05 | 4.355 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 4.421748e-05 | 4.354 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.641282e-05 | 4.249 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.641282e-05 | 4.249 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.271951e-05 | 4.278 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.383959e-05 | 4.269 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.127245e-05 | 4.290 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 6.400674e-05 | 4.194 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 6.707851e-05 | 4.173 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 7.540298e-05 | 4.123 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 7.540298e-05 | 4.123 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 8.190786e-05 | 4.087 | 0 | 0 |
| Disease | R-HSA-1643685 | 8.561413e-05 | 4.067 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 8.941639e-05 | 4.049 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 9.051680e-05 | 4.043 | 1 | 1 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 9.265091e-05 | 4.033 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 9.588328e-05 | 4.018 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.079584e-04 | 3.967 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.295242e-04 | 3.888 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.295242e-04 | 3.888 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.295448e-04 | 3.888 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.311777e-04 | 3.882 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.390099e-04 | 3.857 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.394976e-04 | 3.855 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 1.401181e-04 | 3.854 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.488680e-04 | 3.827 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.655600e-04 | 3.781 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.612406e-04 | 3.793 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.534477e-04 | 3.814 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.782729e-04 | 3.749 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.821415e-04 | 3.740 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.821415e-04 | 3.740 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.959237e-04 | 3.708 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.962770e-04 | 3.707 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.004782e-04 | 3.698 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.099523e-04 | 3.678 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.129961e-04 | 3.672 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.243235e-04 | 3.649 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 2.323050e-04 | 3.634 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 2.323050e-04 | 3.634 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.331042e-04 | 3.632 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.386368e-04 | 3.622 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.859260e-04 | 3.544 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.992228e-04 | 3.524 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 3.159094e-04 | 3.500 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.347129e-04 | 3.475 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.347129e-04 | 3.475 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 3.347129e-04 | 3.475 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 3.347129e-04 | 3.475 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 3.347129e-04 | 3.475 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 3.347129e-04 | 3.475 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.419760e-04 | 3.466 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.544339e-04 | 3.343 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.544339e-04 | 3.343 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.544339e-04 | 3.343 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.544339e-04 | 3.343 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.544339e-04 | 3.343 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.544339e-04 | 3.343 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.544339e-04 | 3.343 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.544339e-04 | 3.343 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.544339e-04 | 3.343 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.544339e-04 | 3.343 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.544339e-04 | 3.343 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.829585e-04 | 3.417 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 3.838637e-04 | 3.416 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 4.041883e-04 | 3.393 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.714109e-04 | 3.327 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.714109e-04 | 3.327 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 5.021664e-04 | 3.299 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.085338e-04 | 3.294 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 5.235580e-04 | 3.281 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 5.235580e-04 | 3.281 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 5.235580e-04 | 3.281 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 5.344171e-04 | 3.272 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 5.357194e-04 | 3.271 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 5.685717e-04 | 3.245 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.685717e-04 | 3.245 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.051305e-04 | 3.218 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 6.076166e-04 | 3.216 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 6.318366e-04 | 3.199 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.318366e-04 | 3.199 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 6.318366e-04 | 3.199 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.454080e-04 | 3.190 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 6.497945e-04 | 3.187 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 6.596114e-04 | 3.181 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 6.848711e-04 | 3.164 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 7.234082e-04 | 3.141 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 7.234082e-04 | 3.141 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 7.234082e-04 | 3.141 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 7.234082e-04 | 3.141 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 7.234082e-04 | 3.141 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 7.234082e-04 | 3.141 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 9.077576e-04 | 3.042 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 7.472330e-04 | 3.127 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 8.305830e-04 | 3.081 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 8.305830e-04 | 3.081 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.623432e-04 | 3.118 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.623432e-04 | 3.118 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 8.279841e-04 | 3.082 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 9.077576e-04 | 3.042 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 7.623432e-04 | 3.118 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.623432e-04 | 3.118 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 9.080707e-04 | 3.042 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.948080e-04 | 3.002 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.005500e-03 | 2.998 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.015303e-03 | 2.993 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.074648e-03 | 2.969 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.087998e-03 | 2.963 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.112929e-03 | 2.954 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.124949e-03 | 2.949 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.130639e-03 | 2.947 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.130639e-03 | 2.947 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.356063e-03 | 2.868 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.405026e-03 | 2.852 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.405026e-03 | 2.852 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.456311e-03 | 2.837 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.461877e-03 | 2.835 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.622943e-03 | 2.790 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.625679e-03 | 2.789 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.653595e-03 | 2.782 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.671647e-03 | 2.777 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.671647e-03 | 2.777 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.690346e-03 | 2.772 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.753313e-03 | 2.756 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.802848e-03 | 2.744 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.949846e-03 | 2.710 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.951874e-03 | 2.710 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.959468e-03 | 2.708 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.008234e-03 | 2.697 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.008234e-03 | 2.697 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.070824e-03 | 2.684 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 2.095268e-03 | 2.679 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.185581e-03 | 2.660 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.232350e-03 | 2.651 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.291765e-03 | 2.640 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 2.353261e-03 | 2.628 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 2.353261e-03 | 2.628 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.353261e-03 | 2.628 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.427204e-03 | 2.615 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.427204e-03 | 2.615 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.209436e-03 | 2.494 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.526518e-03 | 2.597 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.565464e-03 | 2.591 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.669192e-03 | 2.574 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.273102e-03 | 2.485 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.980750e-03 | 2.526 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 2.565464e-03 | 2.591 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.526518e-03 | 2.597 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.980750e-03 | 2.526 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.714635e-03 | 2.566 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.526518e-03 | 2.597 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 3.313563e-03 | 2.480 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.247129e-03 | 2.489 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 2.961458e-03 | 2.528 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 2.961458e-03 | 2.528 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.825966e-03 | 2.549 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.922424e-03 | 2.534 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.825966e-03 | 2.549 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.873656e-03 | 2.542 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.506181e-03 | 2.601 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.247324e-03 | 2.488 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.746213e-03 | 2.561 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.623011e-03 | 2.581 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 2.922424e-03 | 2.534 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 3.091889e-03 | 2.510 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.565464e-03 | 2.591 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 3.314428e-03 | 2.480 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.314428e-03 | 2.480 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 3.314428e-03 | 2.480 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 3.314428e-03 | 2.480 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 3.538660e-03 | 2.451 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 3.669088e-03 | 2.435 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.780340e-03 | 2.422 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 4.213113e-03 | 2.375 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 4.213113e-03 | 2.375 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 4.264604e-03 | 2.370 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 4.483376e-03 | 2.348 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 4.483376e-03 | 2.348 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 4.483376e-03 | 2.348 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.528378e-03 | 2.344 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.738949e-03 | 2.324 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 4.741429e-03 | 2.324 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.781221e-03 | 2.320 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.943954e-03 | 2.306 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 5.142093e-03 | 2.289 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 5.177025e-03 | 2.286 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.281335e-03 | 2.277 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 5.302779e-03 | 2.275 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 5.302779e-03 | 2.275 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 5.302779e-03 | 2.275 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 5.302779e-03 | 2.275 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.411261e-03 | 2.267 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.411261e-03 | 2.267 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.411261e-03 | 2.267 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.411261e-03 | 2.267 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 5.498293e-03 | 2.260 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 5.498293e-03 | 2.260 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 5.810006e-03 | 2.236 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 5.876658e-03 | 2.231 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 5.884113e-03 | 2.230 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.884113e-03 | 2.230 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.884113e-03 | 2.230 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 5.887481e-03 | 2.230 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 5.889673e-03 | 2.230 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.048740e-03 | 2.218 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.048740e-03 | 2.218 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 6.262763e-03 | 2.203 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.352643e-03 | 2.197 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 6.352643e-03 | 2.197 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 6.459357e-03 | 2.190 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.459357e-03 | 2.190 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 6.533561e-03 | 2.185 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 6.698479e-03 | 2.174 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 6.885338e-03 | 2.162 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.932144e-03 | 2.159 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.185932e-03 | 2.144 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.237808e-03 | 2.140 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 7.316074e-03 | 2.136 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 7.549964e-03 | 2.122 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.588599e-03 | 2.120 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 7.588599e-03 | 2.120 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 7.588599e-03 | 2.120 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 7.588599e-03 | 2.120 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 7.633928e-03 | 2.117 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 7.633928e-03 | 2.117 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 7.633928e-03 | 2.117 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 7.633928e-03 | 2.117 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 7.633928e-03 | 2.117 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 7.708248e-03 | 2.113 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 7.820538e-03 | 2.107 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.839976e-03 | 2.106 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 7.839976e-03 | 2.106 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 9.544443e-03 | 2.020 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 9.912295e-03 | 2.004 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.940869e-03 | 2.049 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.038568e-02 | 1.984 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 9.609532e-03 | 2.017 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.609532e-03 | 2.017 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.609532e-03 | 2.017 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 9.609532e-03 | 2.017 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.197273e-02 | 1.922 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 8.803284e-03 | 2.055 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.197273e-02 | 1.922 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.803284e-03 | 2.055 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.803284e-03 | 2.055 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.803284e-03 | 2.055 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.059735e-02 | 1.975 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.059735e-02 | 1.975 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.061297e-03 | 2.043 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.061297e-03 | 2.043 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 8.033277e-03 | 2.095 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 1.158522e-02 | 1.936 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 9.061297e-03 | 2.043 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.940869e-03 | 2.049 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 7.993013e-03 | 2.097 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.091803e-02 | 1.962 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 1.197273e-02 | 1.922 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.676355e-03 | 2.062 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 9.647851e-03 | 2.016 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 9.920483e-03 | 2.003 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.091803e-02 | 1.962 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 8.438458e-03 | 2.074 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.197273e-02 | 1.922 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.113609e-02 | 1.953 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 8.053541e-03 | 2.094 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 8.696461e-03 | 2.061 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 1.185375e-02 | 1.926 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.590151e-03 | 2.018 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 8.940869e-03 | 2.049 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 8.803284e-03 | 2.055 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 9.647851e-03 | 2.016 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.197347e-02 | 1.922 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.227373e-02 | 1.911 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.227373e-02 | 1.911 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.263630e-02 | 1.898 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.263630e-02 | 1.898 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.263630e-02 | 1.898 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.263630e-02 | 1.898 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.299012e-02 | 1.886 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.319347e-02 | 1.880 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.370892e-02 | 1.863 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.370892e-02 | 1.863 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 1.370892e-02 | 1.863 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.375254e-02 | 1.862 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.375254e-02 | 1.862 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.375254e-02 | 1.862 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.382426e-02 | 1.859 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.404492e-02 | 1.852 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.450511e-02 | 1.838 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.470223e-02 | 1.833 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.470223e-02 | 1.833 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.470223e-02 | 1.833 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.472122e-02 | 1.832 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 1.493582e-02 | 1.826 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.507198e-02 | 1.822 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.551094e-02 | 1.809 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.559630e-02 | 1.807 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 1.559630e-02 | 1.807 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 1.559630e-02 | 1.807 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 1.559630e-02 | 1.807 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.615141e-02 | 1.792 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.618797e-02 | 1.791 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.621131e-02 | 1.790 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.621131e-02 | 1.790 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 1.621131e-02 | 1.790 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.630763e-02 | 1.788 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.630763e-02 | 1.788 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.763947e-02 | 1.754 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.763947e-02 | 1.754 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 1.782005e-02 | 1.749 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.782005e-02 | 1.749 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 1.782005e-02 | 1.749 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.782005e-02 | 1.749 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 1.782005e-02 | 1.749 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 1.782005e-02 | 1.749 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 1.782005e-02 | 1.749 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 1.782005e-02 | 1.749 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.788626e-02 | 1.747 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.838586e-02 | 1.736 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 1.890595e-02 | 1.723 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 1.953085e-02 | 1.709 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 1.953085e-02 | 1.709 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.953085e-02 | 1.709 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.953085e-02 | 1.709 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.953085e-02 | 1.709 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.960982e-02 | 1.708 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.960982e-02 | 1.708 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.960982e-02 | 1.708 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.969789e-02 | 1.706 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.984183e-02 | 1.702 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.996480e-02 | 1.700 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.047948e-02 | 1.689 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.047948e-02 | 1.689 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 2.047948e-02 | 1.689 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.086352e-02 | 1.681 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 2.134596e-02 | 1.671 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.220639e-02 | 1.654 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.237833e-02 | 1.650 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.237833e-02 | 1.650 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.326748e-02 | 1.633 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 2.326748e-02 | 1.633 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 2.326748e-02 | 1.633 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.326748e-02 | 1.633 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.342267e-02 | 1.630 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.354186e-02 | 1.628 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 2.354186e-02 | 1.628 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 2.354186e-02 | 1.628 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.354186e-02 | 1.628 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.473573e-02 | 1.607 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.473573e-02 | 1.607 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.524235e-02 | 1.598 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 2.524235e-02 | 1.598 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.524235e-02 | 1.598 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 2.524235e-02 | 1.598 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 2.527867e-02 | 1.597 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 2.604324e-02 | 1.584 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.640979e-02 | 1.578 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 2.702278e-02 | 1.568 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.722407e-02 | 1.565 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.722407e-02 | 1.565 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 2.722407e-02 | 1.565 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.743202e-02 | 1.562 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.743202e-02 | 1.562 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.743734e-02 | 1.562 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 2.743734e-02 | 1.562 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 2.743734e-02 | 1.562 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 2.743734e-02 | 1.562 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.768685e-02 | 1.558 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.768685e-02 | 1.558 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 2.845554e-02 | 1.546 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 2.888442e-02 | 1.539 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 2.940906e-02 | 1.532 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.968906e-02 | 1.527 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.968906e-02 | 1.527 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.968906e-02 | 1.527 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 2.968906e-02 | 1.527 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 2.968906e-02 | 1.527 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 2.968906e-02 | 1.527 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 3.029700e-02 | 1.519 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.029700e-02 | 1.519 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 3.029700e-02 | 1.519 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 3.082851e-02 | 1.511 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 3.082851e-02 | 1.511 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.082851e-02 | 1.511 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.082851e-02 | 1.511 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 3.173674e-02 | 1.498 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 3.205397e-02 | 1.494 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.205397e-02 | 1.494 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 3.205397e-02 | 1.494 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.322974e-02 | 1.478 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.333203e-02 | 1.477 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.333203e-02 | 1.477 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 3.362861e-02 | 1.473 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 3.453335e-02 | 1.462 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.453335e-02 | 1.462 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 3.453335e-02 | 1.462 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 3.453335e-02 | 1.462 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.472714e-02 | 1.459 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.473040e-02 | 1.459 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.473040e-02 | 1.459 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.473040e-02 | 1.459 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 3.496843e-02 | 1.456 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 3.549452e-02 | 1.450 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 3.561787e-02 | 1.448 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 6.996920e-02 | 1.155 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 6.996920e-02 | 1.155 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 6.996920e-02 | 1.155 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 4.293584e-02 | 1.367 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 4.293584e-02 | 1.367 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 4.293584e-02 | 1.367 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 5.178124e-02 | 1.286 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 5.178124e-02 | 1.286 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 5.178124e-02 | 1.286 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 6.121076e-02 | 1.213 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 7.117175e-02 | 1.148 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 7.117175e-02 | 1.148 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 7.117175e-02 | 1.148 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 3.719477e-02 | 1.430 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 3.719477e-02 | 1.430 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 4.699811e-02 | 1.328 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 4.699811e-02 | 1.328 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 4.699811e-02 | 1.328 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 6.833952e-02 | 1.165 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 4.868069e-02 | 1.313 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.868069e-02 | 1.313 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.812627e-02 | 1.318 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 6.996112e-02 | 1.155 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 5.514157e-02 | 1.259 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.989143e-02 | 1.302 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 5.514157e-02 | 1.259 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 5.107879e-02 | 1.292 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 5.186460e-02 | 1.285 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 7.306969e-02 | 1.136 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.056456e-02 | 1.296 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 3.719477e-02 | 1.430 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 7.117175e-02 | 1.148 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 5.793762e-02 | 1.237 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.516737e-02 | 1.258 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 4.561548e-02 | 1.341 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 6.996920e-02 | 1.155 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 6.400143e-02 | 1.194 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 4.575421e-02 | 1.340 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 5.795717e-02 | 1.237 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.717936e-02 | 1.173 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 6.522885e-02 | 1.186 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 4.195158e-02 | 1.377 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 5.516737e-02 | 1.258 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.178124e-02 | 1.286 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.868069e-02 | 1.313 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.868069e-02 | 1.313 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 3.719477e-02 | 1.430 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 4.682966e-02 | 1.329 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.712833e-02 | 1.430 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.945056e-02 | 1.404 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 6.578781e-02 | 1.182 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 5.426360e-02 | 1.265 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 6.121076e-02 | 1.213 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 4.561548e-02 | 1.341 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.623904e-02 | 1.179 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 4.182211e-02 | 1.379 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 7.306969e-02 | 1.136 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.946682e-02 | 1.306 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 5.107879e-02 | 1.292 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 4.757578e-02 | 1.323 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 7.306969e-02 | 1.136 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 5.640749e-02 | 1.249 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 5.640749e-02 | 1.249 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.294651e-02 | 1.201 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.294651e-02 | 1.201 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 4.363778e-02 | 1.360 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 4.118016e-02 | 1.385 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 4.652033e-02 | 1.332 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 4.561548e-02 | 1.341 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.653809e-02 | 1.437 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.991575e-02 | 1.399 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.377350e-02 | 1.195 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 6.121076e-02 | 1.213 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 7.117175e-02 | 1.148 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.117175e-02 | 1.148 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.381752e-02 | 1.195 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 5.514157e-02 | 1.259 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 4.839808e-02 | 1.315 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.381752e-02 | 1.195 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.184601e-02 | 1.378 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.998140e-02 | 1.398 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 4.779365e-02 | 1.321 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.149865e-02 | 1.382 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 3.983984e-02 | 1.400 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.561548e-02 | 1.341 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 7.117175e-02 | 1.148 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 6.377350e-02 | 1.195 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.791684e-02 | 1.237 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 5.770248e-02 | 1.239 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.428160e-02 | 1.354 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.346524e-02 | 1.362 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.377350e-02 | 1.195 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 7.414954e-02 | 1.130 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 7.636053e-02 | 1.117 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 7.725452e-02 | 1.112 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 7.725452e-02 | 1.112 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 7.725452e-02 | 1.112 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 7.725452e-02 | 1.112 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 7.796175e-02 | 1.108 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 7.914512e-02 | 1.102 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.972717e-02 | 1.098 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.972717e-02 | 1.098 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 8.161451e-02 | 1.088 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 8.161451e-02 | 1.088 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 8.161451e-02 | 1.088 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 8.161451e-02 | 1.088 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 8.300741e-02 | 1.081 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 8.301323e-02 | 1.081 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 8.335992e-02 | 1.079 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.425113e-02 | 1.074 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.441974e-02 | 1.074 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.583443e-02 | 1.066 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 8.822141e-02 | 1.054 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 8.822141e-02 | 1.054 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.822141e-02 | 1.054 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 9.018829e-02 | 1.045 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.198350e-02 | 1.036 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 9.249222e-02 | 1.034 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 9.358336e-02 | 1.029 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.358336e-02 | 1.029 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.358336e-02 | 1.029 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 9.358336e-02 | 1.029 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.583124e-02 | 1.018 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.700850e-02 | 1.013 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.719670e-02 | 1.012 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.790778e-02 | 1.009 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.791549e-02 | 1.009 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 9.909596e-02 | 1.004 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 9.923112e-02 | 1.003 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 9.923112e-02 | 1.003 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.923112e-02 | 1.003 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.001261e-01 | 0.999 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 1.030990e-01 | 0.987 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 1.030990e-01 | 0.987 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 1.030990e-01 | 0.987 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.037608e-01 | 0.984 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 1.037608e-01 | 0.984 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.037608e-01 | 0.984 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.037608e-01 | 0.984 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.037608e-01 | 0.984 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.037608e-01 | 0.984 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.043445e-01 | 0.982 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.043445e-01 | 0.982 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 1.047559e-01 | 0.980 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.087013e-01 | 0.964 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.087110e-01 | 0.964 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.088490e-01 | 0.963 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.088490e-01 | 0.963 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.105597e-01 | 0.956 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 1.136107e-01 | 0.945 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.147181e-01 | 0.940 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.153787e-01 | 0.938 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.153787e-01 | 0.938 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 1.153787e-01 | 0.938 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 1.153787e-01 | 0.938 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.165365e-01 | 0.934 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.176310e-01 | 0.929 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.196403e-01 | 0.922 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.196403e-01 | 0.922 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.196403e-01 | 0.922 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 1.196403e-01 | 0.922 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.209726e-01 | 0.917 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 1.237205e-01 | 0.908 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.273068e-01 | 0.895 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.273068e-01 | 0.895 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.273068e-01 | 0.895 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.273068e-01 | 0.895 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 1.273068e-01 | 0.895 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.273068e-01 | 0.895 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.275808e-01 | 0.894 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.275808e-01 | 0.894 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 1.275808e-01 | 0.894 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.284609e-01 | 0.891 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.287970e-01 | 0.890 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.287970e-01 | 0.890 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 1.287970e-01 | 0.890 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.287970e-01 | 0.890 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 1.289268e-01 | 0.890 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 1.350505e-01 | 0.870 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 1.350505e-01 | 0.870 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 1.350505e-01 | 0.870 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 1.350505e-01 | 0.870 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 1.350505e-01 | 0.870 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 1.350505e-01 | 0.870 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.367713e-01 | 0.864 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.395084e-01 | 0.855 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.395084e-01 | 0.855 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.395084e-01 | 0.855 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.395084e-01 | 0.855 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.395084e-01 | 0.855 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.396317e-01 | 0.855 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.406654e-01 | 0.852 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.406654e-01 | 0.852 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.406654e-01 | 0.852 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 1.432494e-01 | 0.844 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.439982e-01 | 0.842 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.451258e-01 | 0.838 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.453381e-01 | 0.838 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.519491e-01 | 0.818 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.519491e-01 | 0.818 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.519491e-01 | 0.818 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.519491e-01 | 0.818 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.519491e-01 | 0.818 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.519491e-01 | 0.818 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.524556e-01 | 0.817 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.524556e-01 | 0.817 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.527606e-01 | 0.816 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 1.539631e-01 | 0.813 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.548917e-01 | 0.810 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.549611e-01 | 0.810 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.589739e-01 | 0.799 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.610657e-01 | 0.793 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.614223e-01 | 0.792 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.614223e-01 | 0.792 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.621473e-01 | 0.790 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 1.658657e-01 | 0.780 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.658657e-01 | 0.780 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 1.692039e-01 | 0.772 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.698187e-01 | 0.770 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.698187e-01 | 0.770 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.698187e-01 | 0.770 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.735564e-01 | 0.761 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 1.756472e-01 | 0.755 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.772139e-01 | 0.752 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.772285e-01 | 0.751 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 1.774195e-01 | 0.751 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 1.774195e-01 | 0.751 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 1.774195e-01 | 0.751 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.787051e-01 | 0.748 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.877153e-01 | 0.727 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 1.955848e-01 | 0.709 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 1.955848e-01 | 0.709 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.955848e-01 | 0.709 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 1.955848e-01 | 0.709 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.955848e-01 | 0.709 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 1.955848e-01 | 0.709 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 1.968398e-01 | 0.706 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.014440e-01 | 0.696 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 2.034822e-01 | 0.691 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 2.034822e-01 | 0.691 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.034822e-01 | 0.691 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 2.034822e-01 | 0.691 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.034822e-01 | 0.691 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.034822e-01 | 0.691 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.034822e-01 | 0.691 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 2.046874e-01 | 0.689 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.046874e-01 | 0.689 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 2.060694e-01 | 0.686 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.095304e-01 | 0.679 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 2.142212e-01 | 0.669 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 2.142212e-01 | 0.669 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 2.142212e-01 | 0.669 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 2.153949e-01 | 0.667 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.166699e-01 | 0.664 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.166699e-01 | 0.664 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 2.166699e-01 | 0.664 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 2.166699e-01 | 0.664 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.166699e-01 | 0.664 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 2.183495e-01 | 0.661 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 2.221035e-01 | 0.653 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 2.221035e-01 | 0.653 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.242469e-01 | 0.649 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.242469e-01 | 0.649 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.242469e-01 | 0.649 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.242469e-01 | 0.649 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.242469e-01 | 0.649 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 2.242469e-01 | 0.649 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 2.242469e-01 | 0.649 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 2.242469e-01 | 0.649 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.242469e-01 | 0.649 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.242469e-01 | 0.649 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 2.242469e-01 | 0.649 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 2.248073e-01 | 0.648 | 0 | 0 |
| Depurination | R-HSA-73927 | 2.248073e-01 | 0.648 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.272898e-01 | 0.643 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 2.274874e-01 | 0.643 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 2.277409e-01 | 0.643 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.299301e-01 | 0.638 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.299301e-01 | 0.638 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.342979e-01 | 0.630 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.342979e-01 | 0.630 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 2.349672e-01 | 0.629 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 2.349672e-01 | 0.629 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.349672e-01 | 0.629 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.349672e-01 | 0.629 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.349672e-01 | 0.629 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.349672e-01 | 0.629 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.349672e-01 | 0.629 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 2.352760e-01 | 0.628 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 2.359470e-01 | 0.627 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 2.370936e-01 | 0.625 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.402201e-01 | 0.619 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.415934e-01 | 0.617 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.427059e-01 | 0.615 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 2.427059e-01 | 0.615 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.432409e-01 | 0.614 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.438579e-01 | 0.613 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.438579e-01 | 0.613 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.438579e-01 | 0.613 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 2.475172e-01 | 0.606 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 2.505014e-01 | 0.601 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.505014e-01 | 0.601 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 2.518893e-01 | 0.599 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 2.518893e-01 | 0.599 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 2.518893e-01 | 0.599 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.518893e-01 | 0.599 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 2.518893e-01 | 0.599 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.518893e-01 | 0.599 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 2.518893e-01 | 0.599 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 2.518893e-01 | 0.599 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 2.518893e-01 | 0.599 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 2.518893e-01 | 0.599 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.534791e-01 | 0.596 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 2.565820e-01 | 0.591 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.565820e-01 | 0.591 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.571792e-01 | 0.590 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 2.639645e-01 | 0.578 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.649546e-01 | 0.577 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 2.728720e-01 | 0.564 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 2.728720e-01 | 0.564 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 2.728720e-01 | 0.564 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 2.785484e-01 | 0.555 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 2.785484e-01 | 0.555 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.785484e-01 | 0.555 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 2.785484e-01 | 0.555 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 2.785484e-01 | 0.555 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.785484e-01 | 0.555 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.785484e-01 | 0.555 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 2.785484e-01 | 0.555 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 2.785484e-01 | 0.555 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.826280e-01 | 0.549 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 2.832801e-01 | 0.548 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.832801e-01 | 0.548 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.832801e-01 | 0.548 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 2.838600e-01 | 0.547 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 2.871917e-01 | 0.542 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 2.914820e-01 | 0.535 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.966030e-01 | 0.528 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.022214e-01 | 0.520 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.024580e-01 | 0.519 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.042591e-01 | 0.517 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.042591e-01 | 0.517 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.042591e-01 | 0.517 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.042591e-01 | 0.517 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.042591e-01 | 0.517 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 3.042591e-01 | 0.517 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 3.042591e-01 | 0.517 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.042591e-01 | 0.517 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.054279e-01 | 0.515 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.098878e-01 | 0.509 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.098878e-01 | 0.509 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.098878e-01 | 0.509 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 3.098878e-01 | 0.509 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 3.098878e-01 | 0.509 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 3.098878e-01 | 0.509 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 3.120442e-01 | 0.506 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 3.231202e-01 | 0.491 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.231202e-01 | 0.491 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 3.231202e-01 | 0.491 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.265197e-01 | 0.486 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 3.290551e-01 | 0.483 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 3.290551e-01 | 0.483 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 3.290551e-01 | 0.483 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.290551e-01 | 0.483 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.290551e-01 | 0.483 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.290551e-01 | 0.483 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 3.290551e-01 | 0.483 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 3.290551e-01 | 0.483 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 3.290551e-01 | 0.483 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 3.290551e-01 | 0.483 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.290551e-01 | 0.483 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.290551e-01 | 0.483 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 3.290551e-01 | 0.483 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 3.290551e-01 | 0.483 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 3.362872e-01 | 0.473 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.362872e-01 | 0.473 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.362872e-01 | 0.473 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.493766e-01 | 0.457 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 3.493766e-01 | 0.457 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.529687e-01 | 0.452 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 3.529687e-01 | 0.452 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.529687e-01 | 0.452 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.529687e-01 | 0.452 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.529687e-01 | 0.452 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 3.529687e-01 | 0.452 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.529687e-01 | 0.452 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.529687e-01 | 0.452 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.529687e-01 | 0.452 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 3.541708e-01 | 0.451 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 3.550413e-01 | 0.450 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 3.611527e-01 | 0.442 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.623772e-01 | 0.441 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.623772e-01 | 0.441 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.623772e-01 | 0.441 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.623772e-01 | 0.441 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 3.631866e-01 | 0.440 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 3.709300e-01 | 0.431 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.709300e-01 | 0.431 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 3.713280e-01 | 0.430 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.752789e-01 | 0.426 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 3.752789e-01 | 0.426 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.752789e-01 | 0.426 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 3.752789e-01 | 0.426 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 3.752789e-01 | 0.426 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 3.760315e-01 | 0.425 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.760315e-01 | 0.425 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.760315e-01 | 0.425 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 3.760315e-01 | 0.425 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 3.760315e-01 | 0.425 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.760315e-01 | 0.425 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 3.760315e-01 | 0.425 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 3.760315e-01 | 0.425 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.760315e-01 | 0.425 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.760315e-01 | 0.425 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.806791e-01 | 0.419 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.832864e-01 | 0.416 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 3.848974e-01 | 0.415 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 3.880721e-01 | 0.411 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 3.880721e-01 | 0.411 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 3.903949e-01 | 0.408 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.969644e-01 | 0.401 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 3.982735e-01 | 0.400 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 3.982735e-01 | 0.400 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.982735e-01 | 0.400 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 3.982735e-01 | 0.400 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 3.982735e-01 | 0.400 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 3.982735e-01 | 0.400 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 3.982735e-01 | 0.400 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.007482e-01 | 0.397 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.097066e-01 | 0.388 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 4.132993e-01 | 0.384 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 4.132993e-01 | 0.384 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.132993e-01 | 0.384 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 4.132993e-01 | 0.384 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 4.132993e-01 | 0.384 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 4.197241e-01 | 0.377 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.197241e-01 | 0.377 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.197241e-01 | 0.377 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 4.197241e-01 | 0.377 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 4.197241e-01 | 0.377 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 4.197241e-01 | 0.377 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.197241e-01 | 0.377 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 4.203696e-01 | 0.376 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 4.257183e-01 | 0.371 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 4.295283e-01 | 0.367 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 4.379986e-01 | 0.359 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 4.379986e-01 | 0.359 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 4.379986e-01 | 0.359 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 4.379986e-01 | 0.359 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 4.379986e-01 | 0.359 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 4.383052e-01 | 0.358 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 4.383052e-01 | 0.358 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 4.398435e-01 | 0.357 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.404112e-01 | 0.356 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.404112e-01 | 0.356 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.404112e-01 | 0.356 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.404112e-01 | 0.356 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.404112e-01 | 0.356 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.404112e-01 | 0.356 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.404112e-01 | 0.356 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 4.404112e-01 | 0.356 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 4.404112e-01 | 0.356 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 4.404112e-01 | 0.356 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 4.404112e-01 | 0.356 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.404112e-01 | 0.356 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 4.438826e-01 | 0.353 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 4.438826e-01 | 0.353 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 4.494966e-01 | 0.347 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.501343e-01 | 0.347 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.501343e-01 | 0.347 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 4.518098e-01 | 0.345 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.570765e-01 | 0.340 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 4.603620e-01 | 0.337 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 4.603620e-01 | 0.337 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.603620e-01 | 0.337 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 4.603620e-01 | 0.337 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 4.603620e-01 | 0.337 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 4.610768e-01 | 0.336 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 4.621202e-01 | 0.335 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 4.621202e-01 | 0.335 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 4.621202e-01 | 0.335 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.621202e-01 | 0.335 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 4.663626e-01 | 0.331 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 4.739515e-01 | 0.324 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 4.771910e-01 | 0.321 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.796027e-01 | 0.319 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.796027e-01 | 0.319 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 4.796027e-01 | 0.319 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 4.796027e-01 | 0.319 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 4.796027e-01 | 0.319 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 4.796027e-01 | 0.319 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 4.796027e-01 | 0.319 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.856240e-01 | 0.314 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 4.856240e-01 | 0.314 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 4.856240e-01 | 0.314 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 4.971340e-01 | 0.304 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.971340e-01 | 0.304 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 4.981585e-01 | 0.303 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 4.981585e-01 | 0.303 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 4.981585e-01 | 0.303 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 4.981585e-01 | 0.303 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 4.981585e-01 | 0.303 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 4.981585e-01 | 0.303 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 4.981585e-01 | 0.303 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 4.981585e-01 | 0.303 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 5.025926e-01 | 0.299 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 5.061407e-01 | 0.296 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 5.084783e-01 | 0.294 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.084783e-01 | 0.294 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 5.104171e-01 | 0.292 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.153333e-01 | 0.288 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.160538e-01 | 0.287 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 5.160538e-01 | 0.287 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.160538e-01 | 0.287 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 5.160538e-01 | 0.287 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.160538e-01 | 0.287 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 5.160538e-01 | 0.287 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 5.160538e-01 | 0.287 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.160538e-01 | 0.287 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.160538e-01 | 0.287 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 5.160538e-01 | 0.287 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.196540e-01 | 0.284 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.204861e-01 | 0.284 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 5.204861e-01 | 0.284 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 5.212268e-01 | 0.283 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 5.212268e-01 | 0.283 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.219967e-01 | 0.282 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.229721e-01 | 0.282 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 5.333120e-01 | 0.273 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.333120e-01 | 0.273 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 5.333120e-01 | 0.273 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.333120e-01 | 0.273 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.333120e-01 | 0.273 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 5.333120e-01 | 0.273 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 5.347937e-01 | 0.272 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 5.414906e-01 | 0.266 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 5.464057e-01 | 0.262 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 5.483506e-01 | 0.261 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.499557e-01 | 0.260 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.499557e-01 | 0.260 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 5.499557e-01 | 0.260 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.499557e-01 | 0.260 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 5.499557e-01 | 0.260 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 5.499557e-01 | 0.260 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.521478e-01 | 0.258 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 5.546957e-01 | 0.256 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.548619e-01 | 0.256 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 5.551716e-01 | 0.256 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 5.626290e-01 | 0.250 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.626290e-01 | 0.250 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.632235e-01 | 0.249 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 5.660069e-01 | 0.247 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.660069e-01 | 0.247 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 5.660069e-01 | 0.247 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 5.660069e-01 | 0.247 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.714889e-01 | 0.243 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 5.722010e-01 | 0.242 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 5.814865e-01 | 0.235 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 5.814865e-01 | 0.235 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.814865e-01 | 0.235 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 5.814865e-01 | 0.235 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 5.814865e-01 | 0.235 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 5.814865e-01 | 0.235 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 5.814865e-01 | 0.235 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 5.814865e-01 | 0.235 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 5.830599e-01 | 0.234 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 5.830599e-01 | 0.234 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 5.834942e-01 | 0.234 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 5.964149e-01 | 0.224 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 5.964149e-01 | 0.224 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 5.964149e-01 | 0.224 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 5.964149e-01 | 0.224 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 5.964149e-01 | 0.224 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 5.964149e-01 | 0.224 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 5.964149e-01 | 0.224 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.027787e-01 | 0.220 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 6.048353e-01 | 0.218 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.108117e-01 | 0.214 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 6.108117e-01 | 0.214 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.108117e-01 | 0.214 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 6.108117e-01 | 0.214 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.108117e-01 | 0.214 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 6.108117e-01 | 0.214 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 6.108117e-01 | 0.214 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.189936e-01 | 0.208 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 6.217848e-01 | 0.206 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.246958e-01 | 0.204 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 6.246958e-01 | 0.204 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 6.246958e-01 | 0.204 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 6.246958e-01 | 0.204 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 6.246958e-01 | 0.204 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 6.246958e-01 | 0.204 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 6.246958e-01 | 0.204 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 6.246958e-01 | 0.204 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.246958e-01 | 0.204 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.380853e-01 | 0.195 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 6.380853e-01 | 0.195 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.380853e-01 | 0.195 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 6.380853e-01 | 0.195 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 6.380853e-01 | 0.195 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 6.380853e-01 | 0.195 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.380853e-01 | 0.195 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 6.380853e-01 | 0.195 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.380853e-01 | 0.195 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 6.380853e-01 | 0.195 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 6.380853e-01 | 0.195 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.380853e-01 | 0.195 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 6.400812e-01 | 0.194 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.509980e-01 | 0.186 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.509980e-01 | 0.186 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 6.509980e-01 | 0.186 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.509980e-01 | 0.186 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 6.509980e-01 | 0.186 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.563375e-01 | 0.183 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 6.634507e-01 | 0.178 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 6.634507e-01 | 0.178 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 6.634507e-01 | 0.178 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 6.634507e-01 | 0.178 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 6.634507e-01 | 0.178 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 6.634507e-01 | 0.178 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.634507e-01 | 0.178 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 6.634507e-01 | 0.178 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 6.634507e-01 | 0.178 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 6.662094e-01 | 0.176 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.697302e-01 | 0.174 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 6.745722e-01 | 0.171 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 6.754599e-01 | 0.170 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 6.754599e-01 | 0.170 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 6.754599e-01 | 0.170 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 6.754599e-01 | 0.170 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.754599e-01 | 0.170 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 6.754599e-01 | 0.170 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 6.754599e-01 | 0.170 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 6.754599e-01 | 0.170 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.827640e-01 | 0.166 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 6.870412e-01 | 0.163 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 6.870412e-01 | 0.163 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 6.870412e-01 | 0.163 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 6.870412e-01 | 0.163 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 6.907863e-01 | 0.161 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.982099e-01 | 0.156 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 6.982099e-01 | 0.156 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 6.982099e-01 | 0.156 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 6.982099e-01 | 0.156 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 6.982099e-01 | 0.156 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 6.993607e-01 | 0.155 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 7.028307e-01 | 0.153 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 7.089807e-01 | 0.149 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 7.089807e-01 | 0.149 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.089807e-01 | 0.149 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.089807e-01 | 0.149 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.089807e-01 | 0.149 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 7.089807e-01 | 0.149 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.138536e-01 | 0.146 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 7.138536e-01 | 0.146 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.193677e-01 | 0.143 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 7.193677e-01 | 0.143 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.193677e-01 | 0.143 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 7.193677e-01 | 0.143 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 7.214447e-01 | 0.142 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 7.276633e-01 | 0.138 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.293846e-01 | 0.137 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.293846e-01 | 0.137 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.293846e-01 | 0.137 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 7.354608e-01 | 0.133 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.354608e-01 | 0.133 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.354608e-01 | 0.133 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 7.368531e-01 | 0.133 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.390446e-01 | 0.131 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.423481e-01 | 0.129 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 7.448355e-01 | 0.128 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 7.448355e-01 | 0.128 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.483603e-01 | 0.126 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 7.483603e-01 | 0.126 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.483603e-01 | 0.126 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 7.483603e-01 | 0.126 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 7.556631e-01 | 0.122 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 7.573440e-01 | 0.121 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 7.629897e-01 | 0.117 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 7.629897e-01 | 0.117 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 7.660075e-01 | 0.116 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.660075e-01 | 0.116 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 7.743622e-01 | 0.111 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 7.743622e-01 | 0.111 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 7.743622e-01 | 0.111 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 7.743622e-01 | 0.111 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 7.797313e-01 | 0.108 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 7.824190e-01 | 0.107 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.824190e-01 | 0.107 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.824190e-01 | 0.107 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 7.824190e-01 | 0.107 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 7.824190e-01 | 0.107 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 7.863747e-01 | 0.104 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 7.901887e-01 | 0.102 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 7.901887e-01 | 0.102 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 7.901887e-01 | 0.102 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 7.920940e-01 | 0.101 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 7.976777e-01 | 0.098 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 7.976814e-01 | 0.098 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 7.976814e-01 | 0.098 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.049069e-01 | 0.094 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.049069e-01 | 0.094 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.118749e-01 | 0.091 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 8.118749e-01 | 0.091 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 8.118749e-01 | 0.091 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.184331e-01 | 0.087 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.185943e-01 | 0.087 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 8.185943e-01 | 0.087 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 8.250742e-01 | 0.084 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 8.250742e-01 | 0.084 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.250742e-01 | 0.084 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 8.271758e-01 | 0.082 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.313230e-01 | 0.080 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.313230e-01 | 0.080 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.313230e-01 | 0.080 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.313230e-01 | 0.080 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.313230e-01 | 0.080 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 8.313230e-01 | 0.080 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 8.331695e-01 | 0.079 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 8.331695e-01 | 0.079 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.373489e-01 | 0.077 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.373489e-01 | 0.077 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.431599e-01 | 0.074 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 8.431599e-01 | 0.074 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 8.487636e-01 | 0.071 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.487636e-01 | 0.071 | 0 | 0 |
| Methylation | R-HSA-156581 | 8.487636e-01 | 0.071 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 8.538342e-01 | 0.069 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.541675e-01 | 0.068 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.551470e-01 | 0.068 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.593786e-01 | 0.066 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.593786e-01 | 0.066 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 8.593786e-01 | 0.066 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.644037e-01 | 0.063 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.692497e-01 | 0.061 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.692497e-01 | 0.061 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 8.692497e-01 | 0.061 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.741517e-01 | 0.058 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.784289e-01 | 0.056 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.784289e-01 | 0.056 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.845083e-01 | 0.053 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 8.869648e-01 | 0.052 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 8.910057e-01 | 0.050 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 8.986599e-01 | 0.046 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.022833e-01 | 0.045 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 9.022833e-01 | 0.045 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.030755e-01 | 0.044 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.041179e-01 | 0.044 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.056801e-01 | 0.043 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.057774e-01 | 0.043 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.057774e-01 | 0.043 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.091468e-01 | 0.041 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.116030e-01 | 0.040 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.123958e-01 | 0.040 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.155289e-01 | 0.038 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.155289e-01 | 0.038 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 9.214635e-01 | 0.036 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.242728e-01 | 0.034 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.269817e-01 | 0.033 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.275906e-01 | 0.033 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.345418e-01 | 0.029 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.375911e-01 | 0.028 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.382331e-01 | 0.028 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.394275e-01 | 0.027 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.413204e-01 | 0.026 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.413204e-01 | 0.026 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.413204e-01 | 0.026 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.434204e-01 | 0.025 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.446339e-01 | 0.025 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.454454e-01 | 0.024 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.510965e-01 | 0.022 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.545353e-01 | 0.020 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.561631e-01 | 0.019 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 9.561631e-01 | 0.019 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.577327e-01 | 0.019 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.577327e-01 | 0.019 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.577327e-01 | 0.019 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.638257e-01 | 0.016 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 9.660398e-01 | 0.015 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.684292e-01 | 0.014 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.727164e-01 | 0.012 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.764222e-01 | 0.010 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.768052e-01 | 0.010 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.796255e-01 | 0.009 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.804950e-01 | 0.009 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.810602e-01 | 0.008 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.817393e-01 | 0.008 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.829858e-01 | 0.007 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.832692e-01 | 0.007 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.866256e-01 | 0.006 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.874457e-01 | 0.005 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.882201e-01 | 0.005 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.908651e-01 | 0.004 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.908794e-01 | 0.004 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.908794e-01 | 0.004 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.919586e-01 | 0.004 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.926986e-01 | 0.003 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.926986e-01 | 0.003 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.931928e-01 | 0.003 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.941194e-01 | 0.003 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.941803e-01 | 0.003 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.947308e-01 | 0.002 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.949718e-01 | 0.002 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.962097e-01 | 0.002 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.969067e-01 | 0.001 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.970226e-01 | 0.001 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.978120e-01 | 0.001 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.979667e-01 | 0.001 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.986728e-01 | 0.001 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.988066e-01 | 0.001 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.992448e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.994371e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.995648e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.996756e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.996836e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.996986e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999228e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999902e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999961e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999965e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.999968e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999975e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999992e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |